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1.INTRODUCTION 
Siddha system of medicine is the most primitive medical system in India. The 
term “Siddha” means achievements and ―Siddhars‖ were saintly persons who 
achieved results in medicine. Siddha system of medicine is originated by first siddhar 
called Lord Siva. It is practiced and taught to next generation by guru disciple 
method.The father of Siddha medicine is the primordial Guru, Agasthiar. 
 
The physiological functioning of based on principle of 96 thathuvam which 
includes the functions of  sensory and motor systems psyco somatic and psyco 
immune system 6 vital centers, 5 kosam(system) which include Circulatory, 
Respiratory , Excretory, Reproductory and Nervous system. 
 
The fundamental principles of Siddha system include theories of Five 
Elements (Aimpootham), and three Vital humor(Mukkuttram). “Health sustainment or 
decline is defined by the Normal or abnormal state of the Humors” .The doshas 
within any person keep changing constantly due to lifestyle, foods and 
environment.The loss of balance among the humors causes energy disharmony and 
physical and mental disequilibrium which may appear at any time and become the 
cause of diseases. According to the Siddhar „Yugi muni‟, the diseases are widely 
classified into 4448 types. Siddha system insists that, the physician should enquire 
into the nature of the disease, its cause and its method of cure and treat it faithfully. 
Envakai Thervukal (The Eight Methods of Examination) are used to determine 
diagnosis, etiology, treatment and prognosis of disease. 
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This art of healing incorporates a variety of holistic practices and remedies. 
The drugs are categorized into three groups, namely herbal products, metal, mineral 
and animal products.32 types of internal medications and 32 external medications are 
adopted. 
―Ntu;ghU jiyghU kpQ;rpdf;fhy; nky;y nky;y 
gw;gk; nre;J}uk; ghNu‖ 
 
In Siddha system of medicine, kazhichal is also known as Athisaaram. Bedhi, 
kirani. As chenduram made from minerals have a long shelf life period when 
compared to herbal products, I have taken Padigalinga chenduram (for my 
dissertation), as a medication for Kazhichal. 
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2. AIM AND OBJECTIVES 
 
 
AIM  
 
 The aim of this study is to do a scientific review to validate the Anti diarroeal,  
Anti spasmodic, and Anti pyretic activity of „PADIGA LINGA CHENDURAM‟ for 
Diarrhoeal by pre-clinical studies.  
 
 
OBJECTIVES: 
 
 The main objective of the present study is to high light the safety and efficacy 
of PADIGA LINGA CHENDURAM  in the treatment of KALICHAL, the following 
methodology was adopted to evaluate the drug and its standardization studies. 
 
 Collection of literature evidence regarding the trail medicine. 
 Identification of the drugs in the padiga linga chenduram 
 Preparation of the trail medicine as per the text. 
 Physico-chemical analysis of Test drug. 
 Evaluation of the toxicity of Test drug. 
 Evaluation of Anti- diarrhoeal activity of the Test drug by in vivo and vitro methods 
 Evaluation of Anti- spasmodic activity of Test drug by in-vitro method. 
 Evaluation of Anti-pyretic activity of Test drug by in-vivo methods 
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3. REVIEW OF LITERATURE 
3.1.LINGAM (CINNABAR) 
3.1.1. GUNAPADAM ASPECT 
SYNONYMS 
,ypq;f ghrhzk; Ngupaw;w NfS 
Ngw;W <Q; ryhl;l fdkhd td;dp nfw;ge; 
jypq;fk; gQ;ruthd; rpe;ijahd; (rpe;jhd;) 
jhd;wd; ed;dpaNjhu; khrkhupNy – rhFq; 
fypq;fkhq; fhuzkh kpyq;fkhFk; 
fhuhQ; rhdpak; kygTQrkhF 
kypq;f khkzp ehfu nkd;W nrhy;Y 
kUtpa Njhu; Ngnuy;uh kypq;fk; ghNu 
 Bhogar nigandu 1200     
Vanni  
Karpam 
Pansaravaan 
Sindaan 
Kalingam 
Maamani 
Naathakaram aankuri 
Maniraagam 
Mileatcham 
Inkulingam 
Raasam 
Kadai vanni 
Kaanjanam  
Kaaranam  
Sandagam 
Samarasam 
Saaniyam 
Chendooram 
Maniraagam 
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Malainasam 
Maninagam 
TYPES  
 Generally lingam is divided in two  
1. Natural lingam 
2. Artificial lingam 
 
NATURAL LINGAM  
 This type of lingam very rare. 
 
ARTIFICIAL LINGAM  
- Ulantha lingam 
 - Rubi lingam 
 - Mathulai lingam 
 - Bombai lingam (or) Mesiri lingam 
 - Nattu (or) china ligam 
 Now- a- days we are getting pure lingam. In sharps we can get (found) 
 In some areas like panjab, Kashmir Rubi lingam. 
 In areas like Chennai , we can‘t able to found that type of lingam and its very rare 
to get that. 
 And there may be difficult in transport to get lingam from long distance. So 
prepare ourselves means that would be fine. So here some preparation method 
(vaipu murai). 
1. BOMBAI LINGA VAIPU: 
 Purified rasam (mercury) – 7 part 
 Purified kandhagam – 2 part 
Purified kanthagam  have to grind both well until rasam mix with it and change of 
colour onto black. 
  After that do 7 seelaiman then dry it well  and put it into glass jar. A medicine 
should be filled half portion of the glass jar. The mouth of the glass jar must be closed 
with maakal, and it have to sealed by 7 seelaiman. Fill a 4 inch of sand into 
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Earthernpot and pan the jar on it and fill the sand  upto the neck of the jar, then closed 
with mud plate gain do 7 seelaiman and dry it up. Heat it for 16 samam (48 hours) 
upto till the sand become red hot, and allow it cool. If we break the glass jar means, 
we can find deporited lingam at mouth of the jar. Then it can be purified and used the 
lingam obtained by this Process is said to be (bombai) lingam or Misiri lingam. 
2. NAATTU LINGA VAIPU: 
  Purified rasam (mercury) – 1 part 
  Purified kandhagam – 1 part 
Do it as said before.  
 
3. ROUMI LINGAM: 
  Purified rasam – 12 parts 
  Purified kanthagam – 8 parts 
  Manoselai – 5 parts 
Do it as said before. 
 
4. MEALAINATTU LINGAM: 
  Purified rasam – 16 ounce 
  Purified kanthagam – 5 ounce  
Both are melt, after the process continue before. 
5. MAATHULAI LINGA VAIPU 
 Purified rasam -  1 part 
 Purified thuttipadanam -  1 part 
 Grind both well and as proceed as before.  
 Anubaha vaidya navaneetham part:4 pg no 4-5. 
  
6. METHOD OF PREPARATION 
Purified mercury  – 280gm 
 Sulphur  _ 70gm 
 Potassium nitrate _ 70mg 
Mercury is thoroughly mixed and triturated with sulphur. Potassium nitrate is then 
added, placed in a conical flask and burnt for 18 hours. After cooling, the red sulphide 
of mercury is collected out. 
 Siddha meteria medica (mineral and animal section) 
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CHARACTER  
 It is hard when it is put into fire it becomes smoke, not soluble in water, it has 
no smell, taste and has hot potency. 
 
ACTION:  
Tonic 
THERAPEUTIC EFFECTS : nghJ Fzk; 
 
“NgjpRuQ; re;jp ngUtpuz ePnuhLj 
fhjfL fhtq; fug;ghd;Gz; - Nzhj 
TUtpypq;f rq;fjkh a+Wfl;L Ak;Nghq; 
FUtpypq;pf rq;fkj;ijf; nfhs; 
 
Mjp apujTUf; fhjyhw; rhjpypq;f 
Nkhjp ypujf Kw;Wlypw; rhjpypq;f 
Fl;lq; fpue;jp nfhLQ;lR+iy wPJGup 
Yl;lq;F Neha;fisNahl; Lk;” 
 
It is indicated to diarrhea, pyrexia, delirium, urticarial, diuresis, tuberculosis, 
scabies, unknown insect bites, syphilis, leprosy, eczema, skin diseases, throbbing pain 
(soolai) and vatha disease  
―epyj;jp nyOe;jgpzp ePq;fhf; fpue;jp 
ryj;JlNd R+iyntb jhdfw;Wk; - gyj;jjhk; 
rhjpypq;fj; jpd;Fzj;lijr; rhw;wpNdd; rd;dpKjy; 
XJRiuk; NghNk xspe;J” 
It has the properties of curing the diseases caused by the earth element and 
cures the diseases caused by the water element. 
 
PURIFICATION 
1. Alangium bark (Alangium savlifolium) – 1400gm is powdered and added with 
vinegar 5.2 litres and placed in dews in the night. The next day it is rubbed and 
kindled well. 35 gm of cinnabar is tied ell in a cloth and put into the above liquid. The 
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pot is covered with another pot sealed with mud pasted cloth, dried and exposed in 
dew for one day. It is heated for 24 hours. Then the cinnabar is taken soaked 
individually with the whole plant of vitis lanata (puli karunai) and indian sarasaparilla 
root as stressed in the following tamil verses. 
 
 
nrhy;yf;Nfs; Gyj;jpaNd kfNd ape;jj; 
Jiwahd rhjpypq;f Rj;jp jhNd 
nty;yf;Nf sopQ;rpy;Gspq; fUid NahL 
Nkyhd ed;dhupf; fhbj; jz;zPu; 
Gy;yf; NfsjpNyhu; %d;W itfy; 
Gifahky; tpsf;fpnyup aOf;F ePq;Fk; 
nty;yf;Nf ssTnjhbf; nfhd;Nw tPir 
ntWe; jz;zPu; ehYgb tPj khNk 
Nkfg; gpzpKjy; Nghf ntd;why; 
Nkyhk; ypq;fk; Rj;jp nra;a  
khfj; jkpQ;rp fUid ehup 
tha;e;j GspeP nuhd;gh ehs; 
ghfj jonyup jPtp ifNghw; 
ghk;Gg; gplfu; ifg;gz; gpnjd 
Ntfkij ePf;nfd whlha; ghk;Ng 
NkyhQ; rhf;fpnjd; whlha; ghk;Ng.” 
 
2. Lime juice, cow‘s milk and the Indian acalypha juice are mixed in equal 
proportion and allowed to fuse cinnabar so as to get it in a consolidated potency state. 
3. When the crude form of red sulphide of mercury is soaked for one day in 
mother‘s milk and lemon juice respectively, it becomes purified 
 Siddha materia medica (mineral and animal section) pg no 222 to 224 
4. Jathi lingam – 35 gm (should be a single piece) 
 Have to place it an nice plate and heat in low flame of hare sire surukittu. Breast 
milk for 2 samam (6 hours). We can do more than 2 samam, while doing like this, 
lingam will be purified well. 
5. Take sufficient amount of lingam and break into small pieces, and tied it up in 
cloth and have it up in small vessels. Fill up ¾ of vessels with bile juice of goat. The 
lingam should be dipped into bile juice in the depth of 4 inches. Boil it in low flame 
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upto water gets drain up. When it gets cool do the same process but have to pour 25 
palam of distilled water that obtained from uvarman.  Again boil it in low flam upto 
that water gets evaporates. Do the same process for 7 types. If it done for 14 times 
mean that would be fine and good for medicine. 
 
6. Lingam – 1part 
Lemon juice – 10 parts 
 Have to powder the lingam in kalvam and pour a lemon juice little by little 
and grind it well. Then make it into small dough; dry it well have to do process for 10 
times, if this is way to purify the lingam. Instead of  lemon juice can use goats milk or 
with breast milk. 
 
7. Auother method: 
Lingam   : 1 palam ( single Bar) 
Breast milk   : 1 Aazhakku 
Honey   : 1 Aazhakku 
Onin juice    : 1 Aazhakku 
Lemon juice  : 1 Aazhakku 
 
Place lingam in iron plate and give surukku by above juice in correct method. This 
is also method of purification of lingam. 
 
8.Auother method: 
Take sufficient amount of lingam, have to grind well with lemon juice in kalvam. 
In this lemon juice should be add little by little and have to grind for 2 samam. After 
that make that into one piece of ball and tied up in cloth and make it to hang in pot. In 
that pot lemon juice should be filled ¼ th for the lingams weight. The lingam should 
be hang and dipped into lemon juice in the depth of 4 inches, and it should not touch 
the bottom of the pot. After this process boil it in low flame up to the juice drains 
completely. Take lingam and place it on glass bowl and make it into dry and powered 
it and preserved it well in separate jar (or) bowl. 
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TOXIC SYMPTOMS OF LINGAM 
 Loss of taste, difficulty in eating and drinking water. 
  Ulcers in the buccal floor,  
Uvula (base of the mouth), 
  Inner portion of the tongue, 
 Larynx and large intestine,  
Foul odour from the mouth,  
Discharge of viscous,  
Whitish saliva,  
Difficult to speak  
Burning sensation are the toxic features of red silphide of mercury 
 
ANTIDOTE: 
 Nutmeg (Myristica fragrans), cubeb pepper (piper cubeba), root bark of red 
cotton tree (gossypium arboretum) and sugar candy each 4.2 gm are made into a 
decoction and administered twice a day for 48 days. 
 Siddha materia medica (mineral and animal section) pg no 233 
 
  OTHER PREPARAIONS WHICH CONTAIN LINGAM AS CHIEF 
INGREDIENTS: 
1. Padigalinga chenduram 
 Dose  : 390mg to 650mg 
 Adjuvant :  Ghee or Butter 
 Indication :  Dysentery, Diarrhea with bleeding, Menorrhagia, 
Cholera and Diarrhea associated with fever. 
 Siddha materia medica (mineral and animal section) : pg no 231 
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2. Linga kattu 
 Adjuvant  :  Thirikadugu Chooranam 
 Indication :  Heart Attack, Diarrhea, Abdominal Distension, 
Delirium And Syncope. 
 Siddha materia medica (mineral and animal section) pg no 230 
 
3. Sandarasa parpam 
 Dose  : 488mg 
 Indication : Diarrhoea, Cholera, Flatulence, Dysentery, Dropsy, 
Anasarca, Jaundice,etc. 
 
4. Linga karuppu  
Dose  : 130mg to 260 
Adjuvant :  Honey and Ghee 
Indication  : Fever, Diarrhea, Urinary disease. 
 Anubhava vaidya navaneetham pg no 9 
 
5. Linga mathirai 
Dose  : One tablet 
Adjuvant :  Sukku kasayam (dry ginger decoction) 
Indication : All type of fever  
 Koshaye anubhoga vaidya pirama ragasiyam pg no.17 
6. Linga kattu  
Adjuvant : Honey, Mothers milk 
Indication : Fever , Headache and Sanni 
 Koshaye anubhoga vaidya pirama ragasiyam pg no.25 
 
7. Linga parpam 
Dose  : 488mg  
Adjuvant : Honey, Ghee, Butter 
Indication : Megam, Thadippu, Vayu 
 Koshaye anubhoga vaidya pirama ragasiyam pg no.28 
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8. Valai sangeevi kgulikai 
Dose  : One tablet 
Adjuvant : Piper battle 
Indication : Fever. 
 Koshaye anubhoga vaidya pirama ragasiyam pg no.84 
 
 
9. Jathi linga mathirai 
Dose  : One tablet 
Adjuvant : Mother‘s milks 
Indication : Sanni, Seethala suram 
 Koshaye anubhoga vaidya pirama ragasiyam pg no.88 
 
10. Agasthiyar linga guzhampu 
Dose  : 488mg 
Adjuvant : Pirandai saaru 
Indication : Abdominal pain 
 Koshaye anubhoga vaidya pirama ragasiyam pg no.93 
 
 
11. Panja padana chenduram 
Dose  : One rice wight 
Adjuvant : Honey and Ginger 
Indication : Fever, Sanni, kuttam, Oral cancer. Cervical cancer. 
 Koshaye anubhoga vaidya pirama ragasiyam pg no.105 
  
12. Linga chenduram 
Dose  : One rice  
Adjuvant : Honey and Ginger 
Indication : Sagala vayu 
 
 Koshaye anubhoga vaidya pirama ragasiyam pg no.106. 
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13. Linga parpam 
Adjuvant : Honey and Ginger 
Indication : Sunni, Kulir suram 
 Koshayea anubhoga vaidya pirama ragasiyam pg no.112. 
 
 
14. Panja sootha mezhugu 
  Dose  : 1 to 2 rice 
  Adjuvant : Pamjaggery and Butter 
  Indication : Fever and Diarrhoeal. 
 Anubava vaidya navaneedham part 7 pgno: 55 
 
15. Linga chenduram 
  Dose  : ½ to 1 rice 
  Adjuvant : Pamjaggery 
  Indication : All type of diarrhoeal 
 Anubava vaidya navaneedham part 4 pgno: 74 
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LINGAM (CINNABAR) 
3.1.2.GEO CHEMICAL ASPECT  
Metonymy 
Eng :  Cinnabar, Vermilion. 
Tam :  Lingam 
San :  Hingula 
Tel :  Ingileekan 
Mal :  Chayilyam 
Can :  Inglika 
Hin :  Sinjraph 
 
INTRODUCTION 
 Cinnabar is one of important mineral derative of mercury. Cinnabar has been 
used for 3000 years ago in Indian medicine. Vermilion is the name given to red 
pigment derived from either natural or artificial cinnabar. This is combination of 
mercury and sulphur. It is pinkish red in colour (Scarlet red) in colour. It is naturally 
available in the mines. But recent days  artificially prepared lingam is available for the 
medicine preparations. This sulphide occurs in nature as a fine grained dark red, very 
heating mercury with sulphur in a retort. However, the natural cinnabar is different 
from artificial cinnabar with impurities and colour changes. The other preparations 
from mercury are: 
1. Cinnabar 
2. Kijjali, the red preparation called rasa sinduram. 
3. Rasakarpura. 
OCCURRENCE: 
 It occurs in many parts of the world particularly in China, United states and 
Spain. 
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GENERAL PROPERTIES 
Chemical formula  : HgS 
Chemical Name   : Mercury II sulphide 
Specific gravity  : 8 
Shape    : Hexagonal 
Colour    : Scarlet red 
Solubility   : Insoluble in water 
Transparency   :  Crystals are translucent to transparent 
 
CINNABAR HAS TWO VARIETIES 
1. Red variety 
2. Black variety 
Cinnabar decomposed by Hot concentrated sulphuric acid, soluble in aquaegia 
ith separation of sulphur and in warm HCL with evaluation of hydrogen sulphide. 
 
ACTION: 
Tonic 
Alterative 
Purgative 
Indirect cholagogue 
Anti septic. 
USES 
1. Mercury preparations have been used for many pears as tonic and alterative 
in western medicine. 
2. Cinnabar is also used to recover gold sediments. 
3. Mercury is used as small proportion in thermometers and Sphygmanometers. 
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Medicinal uses: 
1. Cinnabar preparations are used in treatment for cirrhosis of liver, dyspepsia, 
chronic diarrhea & dysentery. 
2. Cinnabar is used in the treatment where the stools are deficient in bile. 
3. Cinnabar is used in nervous disorders. 
4. Cinnabar used in the treatment for fever, ascites, asthma and other forms of 
difficulty in breathing. 
5. Used for  skin disease like ringworm, eczema, psoriasis etc 
6. Cinnabar used in the treatment of syphilis. 
7. Powders of cinnabar dusted into the eyes are useful collyrium to cure 
ophthalmia. 
TOXICITY OF CINNABAR 
1. Over dose or long continued use of mercurial preparations produce a set of 
symptoms called as mercurialism. 
2. In such cases, profuse salivation, swollen and spongy gums, swelling of 
tongue, loosening of teeth etc. 
3. The long term uses of cinnabar medicines are result in renal dysfunction 
due to deposition of mercury in kidney. 
4. Most of the soluble salts of mercury are absorbed slowly from intact 
mucous membrane of alimentary tract and finally excreted into caecum and 
faeces and produce their toxic effects. 
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3.1.3.LATERAL RESEARCH  
LINGAM 
Exposure to Low Dose of Cinnabar (a Naturally Occurring Mercuric Sulfide 
(HgS)) Caused Neurotoxicological Effects in Offspring Mice 
 
In conclusion, our results provide a toxicological basis for cinnabar-induced 
neurotoxic and ototoxic effects in offspring mice, which may be extrapolated to adults 
and children exposed to therapeutic dosage in TCM. Changes in NOx levels and 
Na+/K+-ATPase activities appear to be the underlying mechanism of the toxicological 
effects of cinnabar, which may supply an important and useful biomarker in offspring 
exposure to low dose and long-term mercuric compounds-induced neurotoxicity. 
 http://www.hindawi.com/journals/bmri/2012/254582/ 
 
Neurotoxic Mechanism of Cinnabar and Mercuric Sulfide on the Vestibulo-
Ocular Reflex System of Guinea Pigs 
 http://toxsci.oxfordjournals.org/content/67/2/256.full 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PRE CLINICAL STUDY OF PADIGALINGA CHENDURAM Page 18 
 
3.2.PADIKARAM (ALUM) 
3.2.1. GUNAPADAM ASPECT 
 
SYNONYMS 
 
“rPdj;jpd; Ngu;jidNa nrhy;yf; NfS 
rpwe;j ntz; fhupjhd; gofprPdp 
khdj;jpd; kpd;Nghy nts;sr;rpahFk; 
kfj;jhd ghzpr;rp FUr;rpahk; 
ghDj;jp Dg;Gf;F rj;JU NtahFk; 
ghq;fhd ntz;ePyp fLQ; Rz;zj;jp  
fhdj;jpd; fLQ; rPd NgUkhFq; 
fLQ;Rz;z KiwfSf;F  ajid ehl;Nl” 
 Boghar nigandu 1200 
 
Vennkari 
Cheeni 
Panitchi 
Uppusathru 
Kadumsunnathy 
Padugi 
Vellatchi 
Kurutchi 
Venneeli 
Cheena kaaram 
Chenam  
 
PRE CLINICAL STUDY OF PADIGALINGA CHENDURAM Page 19 
 
OCCURRENCE 
Nepal 
Kathiyawar 
Panjab 
Bihar 
PANJABOOTHAM 
“gypj;jpl;l rTf;fhul; gQ;r g+jg;  
gadhfg; gz;zpNa ghu;j;j Neu;ik  
Ngypj;jpl;lgpUjptpkz; fy;Yg; ghr;R  
Nguhd tg;GryQ; rj;jpr; rhuk;  
njypj;jpl;l NjAtJ ntLAg; ghNk 
nraePu;jhd; jPnad;Nw nrg;g yhFk; 
typj;jpl;l thAtJ fhw;Wr; rPd 
kfj;jhd thfhrk; G+eP whr;Nr” 
 Agathiya Vazhalai Pannirandu 
The pancha bhootha salts are: 
 Earth (nilam) - Kalluppu (Crystalline salt) 
 Water (neer) - Sathicharam  (An acid salt) 
 Fire (thee) - Vediyuppu (Potassium nitrate) 
 Air (kaatru) - Seenam (Alum) 
 Sky   Pooneeru (fuller‘s earth) 
 
CHARACTER 
 White in colour 
 Transparent crystals  
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TASTE 
Sweet 
Sour 
Astringent 
ACTIONS 
 Astringent  
Antiseptic 
Antispasmodic 
 Siddha material medica (mineral and animal section) 
Caustic 
Haemostatic 
Irritant and purgative in large doses 
Emetic in repeated doses 
 Indian meteria medica vol – 2 pg no 2  
 
THERAPEUTICAL EFFECT: 
“rPdnkDq; fhukJ rPwptU gy;yuiz 
Midg;ghy; fz;Nzha; mdpynkhL – khepyj;jpy; 
Jd;khq; fprk;thA Njhyhj cs;soiy 
Fd;kkpit Nghf;F nkdf; $W” 
 Gunapadam thathu geevam 
It cure, gingivitis, eye diseases, ophthalmia, elephantiasis, vayu, tumour, seen 
of heat, gastric ulcer, hypertension, haemorrhage, dysentery, diarrhea, children‘s 
vomiting, diarrhea, whooping cough, spittle cough with expectorant, pharyngitis, 
menorrhagia and gonorrhea. 
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PURIFICATION AND DETOXIFICATION 
  The alum is dissolved in water filtered, boiled when it attains consistency of 
jelly. It is cooled to get the purified form. 
 USES 
 1. Alum (130 mg) is dissolved in 1 ounce of water and on washing it controls eye 
diseases. 
 2. Alum (35gm) dissolved in 10.4 liters of water is used as a mouth wash     and 
for washing the ulcers. 
 3. When a cloth is soaked in alum dissolved water is applied over the cut injuries, 
it may arrests bleeding. 
 4. Alum, acacia catechu and bark of cinnamomum zeylanica (equal Quantities) 
are powdered and mixed with 975 mg of honey and give to control diarrhea due to 
tuberculosis. 
 5. It also controls vomiting when given at a dose of 65 mg. 
 6. When the alum 195 gm is dissolved in rose water 14ml and administered twice 
dily, the cough associated with asthma is controlled. 
 7. Alum (65 to 130 mg) is dissolved in distillated of (Trachyspermum ammi) 
bishop‘s weed theeneer and administered in whooping cough to control effectively. 
 8. For whooping cough and chronic hiccup that produce vomiting it is given with 
honey in the dose of 4 gm. 
 9. Alum (4.7 gm) dissolved in butter milk is given for snake bite. 
 10. For severe head injury, alum (130) is administered along with sugar. 
 11. Alum (2.6 gm) is given with sugar syrup for guinea worm infestation. 
 12.  In leucorrhoea with bleeding, alum is given with the juice of Adathoda 
vasica thrice daily. 
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 13. Alum is boiled along with and filtered; the filtrate effective in the 
management of excessive menstrual blood flow; it is also effective in the treatment of 
toxic fever and heamorrhoid. 
 14. Alum is dissolved in water and applied tropically to control the bleeding in 
nose, teeth and penis. 
 15. Alum is used in hair dye preparations. 
 16. Alum is powdered and sprinkled on the pulp of aloes to get its juice. 
USES: 
 It is useful in leucorrhoea, haematuria, haeoptysis, menorrhagia, gastric and 
intestinal catarch & other haemorrhages, in chronic diarrhoea and dysentery and in 
atonic discharges generally. 
 In chronic diarrhoeas, a mixture containing 10 grains of alum, 5 drops of 
laudanum and 1 ½ ounces of infusion of acorus root, given thrice daily is useful. 
 In the diarrhoea preceding eholera and in the diarrhoea of phthisis, a 
compound powder of alum, catechu and cinnamon each 10 grain mixed with honey is 
given in reprated doses. It is useful also in strangery and vomiting in small doses i.e 2 
to 10 grains of it arrests the spasms of asthuma.  
 
 In narcotic poisoning in children it is a good and efficient antidote. In 
whooping cough, after the first or acute stage has passed, alum in doses of 2 – 4 
grains according to age of the child, given twice or thrice a day in the form of powder 
or in solution in omum water (1 in 60) in doses of a teaspoonful to a dessertspoonful 
for a child from 1 to 4 years old, given thrice a day is most beneficial. For asthuma & 
cough alum 5 grains in half an ounce of rose water is given twice a day. 
 In obstinate cases of malaria desiccated alum in 5 grain doses with some 
aromatic compound powder to disguise the taste given 2 hours before the expected 
rigour with only a  teaspoonful of water has given very satisfactory results. 
  In obtained hiccup one drachm doses given two or three times a day induce 
vomiting and stop hiccup. 
  Alum 45 grains mired with treack is given internally for guinea – worm. 
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  Alum in 5 grain doses thrice a day with the juice of adhathoda vasica works 
wonderfully in certain form of leucorrhoea, especially when the flow is tinged with 
blood. 
 
Alum whey or ―line whey‖ prepared by boiling for 10 minutes 2 drachms of 
powdered alum in a pint of milk and strained in beneficial in doses of ½ to 2 ounces 
thrice daily in menorrhagia and bleeding piles. ―As a haemostatic, its use is 
recommended in bleeding from the nose and other mucous surfaces.‖ Dr.H.C. Sen has 
―derived satisfactory results‖ from alum – whey in cases of enteric fever. 
EXTERNALLY 
 Alum forms one of the in gredients of some hair dyes and hair lotions. 
It is applied in a saturated solution i.e 5 percent in bleeding from nose, gums, 
vagina or the rectum, as a styptic in leech bites, cuts etc. in protopses ani and 
prolopsus uteri. 
Locally applied it checks weats in the armpits, groins and soles of the feet. 
Weak solution is used as a lotion to ulcers and chilblains; as ―an astringent 
gargle in a strength of 2 draehms to a pint of decotion of gall or Babul dark or of plain 
water‖. It is used in relaxed or ulcerated sore – throut, aphonaia, atony of the larynx 
spongy or bleeding gums, loose teeth, ulcers of the mouth and tongue, fissures of the 
tongue in consumption, in excessive salivation etc, it is locally applied in diphtheria, 
croup and pharyngitis; as a collyrium it is used in chronic and purulent ophthalmia, 
chronic conjunctivitis. 
―Alum lotion, internally is administed to check haemorrhage from lungs, 
stomach, kidney and other organs or to arrest excessive menstrual flow‖ 
In inflammation round the ear a paste made of alum and gypsum equal parts 
and gile Armani, is applied, in otorrhoea it may be dropped into the ear. 
In apththae and thrush, sporgy gums and other affections of the mouth 
powdered alum with honey is used with benefit. It is often sprinkled over indolent 
ulcers, especially chronic umbilical ulcers of infants and used as a snuff in eoistaxis or 
a gauze wet with alum lotion is plugged in the nose. 
In cases of past partum hemorrhages or menorrhagia, sterilized cotton plugs 
saturated with alum powder or sterilized alum lotion immediately stop the bleeding. 
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In discharges from the urethra, caused by a sore or excoriated surface between 
the prepuce and the head of the penis often confounded with gonorrhea, a 4 P.C 
Solution applied twicw or thrice daily is very beneficial. 
 For bed sores or where these are likely to occur, a meture of 30 gains of burnt 
alum & the white of an egg, is painted over the past. 
 Indian meteria medica vol 2 pg no: 2-6.  
 
ARTIFICIAL ALUM 
  “rPd itg;G nry;YNtd; rPdk; njhFFwpNghy; 
   ey;Y tUg;Gq; fy;Yg;G nuz;L 
  ky;Yk; gor;rhWk; japu; tpl;L 
   gy;YWthf ghz;lj;jpu; %Nl 
  %bNa rhzp KOtJNk G+rp 
   ehbNa Mtpd; gjpjhdpw;whf;Ff; 
  $bNa kz;lyq; Fwpg;ghf itj;Jj; 
   NjbnaLf;f rpdK khr;Nr” 
 “ghug;gh ruf;fpDl itg;Gf;NfS 
 ghUg;G jd;DNd fy;Yg;Gq; $l;b 
Ciug;gh gor;rhW japUq;$l;b 
 cld; Nru;j;J ghz;lj;jpy; tpl;L %b 
fhug;gh Fopntl;b naUitg; Nghl;L 
 fUthd ghz;lkij ajd;Nky; itj;J 
Nrug;gh vUg;Nghl;L rkhjp itj;jhy; 
Jpwkhf kz;lyj;jpy; rPdkhr;Nr” 
 Agathiyar amudha kalaienanam 1200, pg no 647 
 
1. Padigam vaippu  
 Annapaethy  - 4 parts 
 Yellow yolk - 1 part 
 Pioneer - 1 part 
Water  - 72 parts 
 Mix all those things and dry it up by flaming it well undisturbed this upto 5 
months. After 5 months have pour water for 10 to 15 days dry it again and use it 
medicine. 
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2. Yellow alum  
 The method to prepare yellow padigaram as said before in padigaram vaippu by 
using yellow annapaethy. 
 For a sufficient amount of padigaram take 18 portion of water and mix with it then 
filter it well. Take 1 portion of that distilled water and for this required amount of 
yellow yolk is 9 portions. In 1:9 ratio mix well and flame it well. 
 
3. Green alum 
 Take sufficient amount of white padigaram and mix it in 18 portions of water, and 
filter it without silt. Mix this distilled water with Jangal green in the ration of 1:4, and 
dry it up by flaming or by sunlight. 
 Sufficient amount yellow padigaram and mix it with 18 portions of water. If we put 
copper powder in this water it will turns into green colour. After the change of colour 
make it filter without silt and preserved in glass jar.  
 Take sufficient amount of white padigaram in glass bowl, and mix 18 portions of 
water and filter it well pour this filtered water in copper pot. Put ½ navatcharam into 
it, and leave it for few days. After that dry it by flamming. 
 As said before, By mixing yellow padigaram and water then take distilled water. Add 
half portion of jangal green powder to the weight of yellow padigaram. Mix well and 
filter it without silt and flame it well and then use it for medicine. 
 
4. Red alum 
 Sufficient amount of white padigaram and to add 18 portions of water and filter it. In 
this distilled water (10 portions) and add 2 portion of jangal green and mix well. It 
will turns into red colour, after that flame it and used it for medicine. 
 
 Sufficient amount of venkaram and to this pour 10 portions of water, mix well and 
distilled it without silt. Take 4 portion distilled water and to this add 1 portion of 
white padigaram; then mix well and flame it well and take it and dry it up by sunlight. 
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OTHER PREPARAIONS WHICH CONTAIN ALUM AS CHIEF 
INGREDIENTS: 
 
1. Padigara parpam 
Dose  : Pepper (milagu) 
Adjuvant : Butter 
Indication :  Leucorrhoea 
 Koshaye anubhava vaidya piramaragaciyam  pg no 30 
 
2. Unani chenduram 
Adjuvant : Ghee and Butter 
Indication : Menorrhagia and Leucorrhoea 
 Koshaye anubhava vaidya piramaragaciyam  pg no 36 
 
3. Padigara parpam 
Dose  : 130mg to 260 mg 
Adjuvant : Butter  
Indication : Leucorrhoea and diarrhea. 
 Uyir kakkum siddha Maruthuvam pg no : 526 
 
 
4. Sandarodhaya kulikai  
Dose  : 2 
Adjuvant : Honey 
Indication : Fever 
 Saraboji vaidya thirattu pg no 68 
 
5. Padiga thalaga parpam 
Dose  : Dhuvarai  
Adjuvant : Honey 
Indication : Fever, cough and Asthma 
 Saraboji vaidya thirattu pg no 87 
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6. Padigalinga chenduram 
Dose  : 488mg 
Adjuvant : Ghee and Honey 
Indication : diarrhea and chest disease 
 Saraboji vaidya thirattu pg no 99 
 
7. Ukkira veera chenduram 
Dose  : 488mg 
Adjuvant : Ghee and Butter 
Indication : leucorrhea, menorrhagia, Madhu megam (DM) 
 Saraboji vaidya thirattu pg no 103 
 
8. Suvarna boopathy kuligai 
Dose  : 1 
Indication : Sanni, yelai, kasam 
 Kannusamy sigitcha rathina deepam pg no 44 
 
9. Padigara parpam 
Dose  : 130mg to 195mg 
Adjuvant : Butter  
Indication :  Vomiting  
 Kannusamy sigitcha rathina deepam pg no 214 
 
 
10. Padigara mathrai 
Dose  : Milagu to pattani 
Adjuvant : Honey 
Indication : Diarrhoea, cough and abdominal discomfort. 
 Kannusamy  paramparai vaidyam pg no 148 
 
11. Padikavengara parpam 
Dose  : 1 to 4 Kundri 
Adjuvant : Ghee, Butter 
Indication : Neer kattu, Thasai adaippu 
 Siddha vaidya thirattu pg no: 127 
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PADIKARAM (ALUM) 
3.2.2.GEO CHEMICAL ASPECT 
ALUMEN (ALUM) 
  Potassium alum 
 K2 SO4 Al2(So4)3 24H2 O 
An alum is a double sulphate formed by the union of a sulphate of aluminum, 
chromium, manganum or Ferrum with a Sulphate of an alkaline metal of group like 
Potassium, Sodium or Ammonium. 
 The official alum is Aluminum and Potassium Sulphate or potassium Alum 
which becomes Alumen Exsiccatum. Dried Alum when the molecules of water are 
driven off. 
 
PHYSICAL PROPERTIES 
 Solubility  : water soluble 
 Diapheny : Transparent 
 Lustre : Vitreous 
 Colour : Colour less, white 
 Luminescence : Non-Fluroscent 
 Hardness(moh‘s) : 2-Gypsum 
 Cleavage : Indistinct 
 Streak : white 
 
CHEMICAL PROPERTIES 
 Chemical formula : K Al (So4)2 12H2 O 
  
CHARACTERISTICS 
Potassium alum crystallizes in regular octahedral with flattened corners, and is 
very soluble in water. The solution reddens litmus and is an astringent. When heated 
to nearly a red heat it gives a porous, friable mass which is known as "burnt alum." It 
fuses at 92 °C (198 °F) in its own water of crystallization. "Neutral alum" is obtained 
by the addition of as much sodium carbonate to a solution of alum as will begin to 
cause the separation of alumina. 
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MINERAL FORM AND OCCURRENCE 
Potassium alum or alum-(K) is a naturally occurring sulfate mineral which 
typically occurs as encrustations on rocks in areas of 
weathering and oxidation of sulfide minerals and potassium-bearing minerals. In the 
past, alum was obtained from alunite, a mineral mined from sulfur-containing 
volcanic sediments source.
[6]
 Alunite is an associate and likely potassium and 
aluminium source.
[1][7]
 It has been reported at Vesuvius, Italy, east of 
Springsure, Queensland, Alum Cave, Tennessee, Alum Gulch, Santa Cruz County, 
Arizona and the Philippine island of Cebu. A related mineral is kalinite, a fibrous 
mineral with formula KAl(SO4)2·11H2O 
USES 
Chemical 
 in tanning of leather to prepare the hide 
 as a mordant for dyes 
 in the clarifying of turbid liquids, including post-storm treatment of lakes to 
precipitate contaminants 
 as a fire retardant in textile products 
 (historically) as a hardener for photographic emulsions (films and papers), usually 
as part of the fixer. Modern alternatives are superior. 
 
Medicinal 
 As an astringent/styptic and antiseptic. 
 As a natural deodorant by inhibiting the growth of the bacteria responsible 
for body odor. 
 After shaving to prepare the skin 
 To reduce bleeding in minor cuts and abrasions, nosebleeds, and hemorrhoids. 
CULINARY 
 As an additive to baking powder to provide a second leavening phase at high 
temperatures. 
 To preserve and add crispness to fruit and vegetable especially when pickling. 
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TRADITIONAL 
 In Ayurveda, where it is called phitkari or saurashtri 
In traditional Chinese medicine it is called ming fan. 
TOXICOLOGY AND SAFETY 
Alum, any of a group of hydrated double salts, usually consisting ofaluminum 
sulfate, water of hydration, and the sulfate of another element. A whole series of 
hydrated double salts results from the hydration of the sulfate of a singly charged 
cation (e.g., K
+
) and the sulfate of any one of a number of triply charged cations 
(e.g., Al
3+
). Aluminum sulfate can thus form alums with sulfates of the singly charged 
cations of potassium, sodium, ammonium, cesium, and other elements and 
compounds. In similar fashion, sulfates of the triply charged cations of iron, 
chromium, manganese, cobalt, and other metals may take the place of aluminum 
sulfate. The most important alums are potassium aluminum sulfate, ammonium 
aluminum sulfate, and sodium aluminum sulfate. Potassium aluminum sulfate, also 
known as potassium alum or potash alum, has a molecular formula of 
K2(SO4)·Al2(SO4)3·24H2O or KAl(SO4)2·12H2O. 
Alums can easily be produced by precipitation from an aqueous solution. In 
producing potassium alum, for example, aluminum sulfate and potassium sulfate are 
dissolved in water, and then upon evaporation the alum crystallizes out of the 
solution. A more common production method is to treat bauxite ore with 
sulfuric acid and then with potassium sulfate.Ammonium alum is produced by the 
evaporation of a water solution containing ammonium sulfate and aluminum sulfate. 
It can also be obtained by treating a mixture of aluminum sulfate and sulfuric acid 
with ammonia. Alums occur naturally in various minerals. Potassium alum, for 
example, is found in the minerals kalinite, alunite, and leucite, which can be treated 
with sulfuric acid to obtain crystals of the alum. 
Most alum has an astringent and acid taste. They are colourless, odourless, and 
exist as a white crystalline powder. Alums are generally soluble in hot water, and they 
can be readily precipitated from aqueous solutions to form large octahedral crystals. 
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3.2.3LATERAL RESEARCH 
ALUM 
SPECIAL FEATURE: IMMUNOLOGICAL ADJUVANTS 
The problem with pure recombinant or synthetic antigens used in modern day 
vaccines is that they are generally far less immunogenic than older style live or killed 
whole organism vaccines. This has created a major need for improved and more 
powerful adjuvants for use in these vaccines. With few exceptions, alum remains the 
sole adjuvant approved for human use in the majority of countries worldwide. 
Although alum is able to induce a good antibody (Th2) response, it has little capacity 
to stimulate cellular (Th1) immune responses which are so important for protection 
against many pathogens. In addition, alum has the potential to cause severe local and 
systemic side-effects including sterile abscesses, eosinophilia and myofascitis, 
although fortunately most of the more serious side-effects are relatively rare. There is 
also community concern regarding the possible role of aluminium in 
neurodegenerative diseases such as Alzheimer's disease. Consequently, there is a 
major unmet need for safer and more effective adjuvants suitable for human use. In 
particular, there is demand for safe and non-toxic adjuvants able to stimulate cellular 
(Th1) immunity. Other needs in light of new vaccine technologies are adjuvants 
suitable for use with mucosally-delivered vaccines, DNA vaccines, cancer and 
autoimmunity vaccines. Each of these areas are highly specialized with their own 
unique needs in respect of suitable adjuvant technology. This paper reviews the state 
of the art in the adjuvant field, explores future directions of adjuvant development and 
finally examines some of the impediments and barriers to development and 
registration of new human adjuvants. 
 http://www.nature.com/icb/journal/v82/n5/full/icb200475a.html 
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3.3.DISEASE REVIEW 
3.3.1.KAZHICHAL  - SIDDHA ASPECT  
Vernacular names: 
  Migu Kalichal 
  Athisaaram 
Introduction 
Intaken foods are completely or incompletely digested sometimes 
immediately after the food taken. It can be evacuate through intestine 
without storage, all ingested foods are frequently evacuated is termed as 
perunkalichal. 
Aetiology   
 Excess of Carbohydrates  
   Eg : maapandam 
 Excess of fatty foods 
   Eg : oil., ghee., Non vegetarian items 
 Decomposed fish Vegetables 
 Easily undigestable foods 
   Eg: pulak., kichadi. 
 Excess of worm infections 
Types: 
Perunkalichal is divided into 
1. Vatha Perunkalichal 
2. Pitha Perunkalichal 
3. Kabha Perunkalichal 
4. Mukutra Perunkalichal 
5. Sura Perunkalichal 
6. Paya Perunkalichal 
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7. Thukka Perunkalichal 
8. Kuruthi Perunkalichal 
1. Vatha Perunkalichal 
Flatulence 
Frequent evacuation 
Stools with blackish or yellowish colour and unpleasant odour 
Stomach pain 
Belching 
2. Pitha perunkalichal 
Flatulence 
Vomiting 
Pain around umbilicus 
Stools with blood yellowish &frothy 
Oedema in legs &hands 
 
3. Kabha Perunkalichal 
Abdominal pain during evacuation 
Sputum like stools appearance 
Frothy,  unpleasant odour in stools. 
4. Mukutra Perunkalichal 
The symptoms occurs in the combination of vadha, pitha and kabha 
perunkalichal 
5. Sura Perunkalichal 
High fever 
Sometimes like typhoid & thyphus 
6. Paya & Thukka Perunkalichal 
Perunkalichal occurs in fear 
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7. Thoda Perunkalichal 
Perunkalichal occurs in children 
8. Kuruthi perunkalichal 
Spicy foods, 
Mercury, arsenic preparations are taken in high doses irritate the 
intestine and produce kuruthi kalichal. 
Over doses of internal medicine like serankottai and kundrimani. 
ehb 
1. “rpwg;ghd thjj;jpy; c~;ze; jhNd 
Nru;e;j njdpy; mjprhuk;” 
2. “jiog;ghd gpj;jjl;jpy; c~;zk; Nru;e;jhy; 
Mjprhue;jhd;” 
3. cWjpAs;s gpj;jkJ Njhd;wpy;.. mjprhuk; 
4. jhdKs;s Nrj;Jke;jh dpsfpy;…….. mjprhuk; 
5. “rpwg;ghd Nrj;Jkj;jpy; gpj;je;jhd; 
vOe;jZfply; mjprhue; jhdhFNk” 
 (rjfehb) 
Some of the medicines for diarrhea: 
Kudineer 
Maramanjal kudineer 
Athividaya kudineer 
Thippiliyathi kudineer 
Chooranam 
Thayeerchundi chooranam 
Sunndaivatral chooranam 
Thaalisa podi 
Anna podi 
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Vadagam 
Thaalisaathi vadagam 
Pirandai vadagam 
Vaazhaipoo vadagam 
Mathirai 
Kabaada mathirai 
Kattuvaathi mathirai 
Ouzhi mathirai 
Vajrakabaada mathirai,  
Jathikkai mathirai 
Parpam 
Naaga parpam 
Pavala parpam 
Chenduram 
Uppu chenduram 
Annapaethi chenduram 
Lingathuvar 
Manapaagu 
Vilva manapaaagu 
Chemparuthi manapaagu 
Kudasa manapaagu 
Ilagam 
 Saathikaai ilagam 
Inji ilagam 
Vilvathy ilagam 
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3.3.2.MODERN ASPECT  
 DIARRHOEA 
INDRUDUCTION 
Diarrhoeal disease is the second leading cause of death in children under five 
years old, and is responsible for killing around 760 000 children every year. Diarrhoea 
can last several days, and can leave the body without the water and salts that are 
necessary for survival. Most people who die from diarrhoea actually die from severe 
dehydration and fluid loss. Children who are malnourished or have impaired 
immunity as well as people living with HIV are most at risk of life-threatening 
diarrhoea. 
 
Diarrhoea is defined as the passage of three or more loose or liquid stools per 
day (or more frequent passage than is normal for the individual). Frequent passing of 
formed stools is not diarrhoea, nor is the passing of loose, "pasty" stools by breastfed 
babies. 
 
Diarrhoea is usually a symptom of an infection in the intestinal tract, which 
can be caused by a variety of bacterial, viral and parasitic organisms. Infection is 
spread through contaminated food or drinking-water, or from person-to-person as a 
result of poor hygiene. 
 
Interventions to prevent diarrhoea, including safe drinking-water, use of 
improved sanitation and hand washing with soap can reduce disease risk. Diarrhoea 
can be treated with a solution of clean water, sugar and salt, and with zinc tablets. 
There are three clinical types of diarrhoea: 
 
 acute watery diarrhoea – lasts several hours or days, and includes cholera; 
 acute bloody diarrhoea – also called dysentery; and 
 persistent diarrhoea – lasts 14 days or longer. 
 
SCOPE OF DIARRHOEAL DISEASE 
Diarrhoeal disease is a leading cause of child mortality and morbidity in the 
world, and mostly results from contaminated food and water sources. Worldwide, 780 
PRE CLINICAL STUDY OF PADIGALINGA CHENDURAM Page 37 
 
million individuals lack access to improved drinking-water and 2.5 billion lack 
improved sanitation. Diarrhoea due to infection is widespread throughout developing 
countries. 
In developing countries, children under three years old experience on average 
three episodes of diarrhoea every year. Each episode deprives the child of the 
nutrition necessary for growth. As a result, diarrhoea is a major cause of malnutrition, 
and malnourished children are more likely to fall ill from diarrhoea. 
 
 SECRETORY 
Secretory diarrhea means that there is an increase in the active secretion, or 
there is an inhibition of absorption. There is little to no structural damage. The most 
common cause of this type of diarrhea is a cholera toxin that stimulates the secretion 
of anions, especially chloride ions. Therefore, to maintain a charge balance in 
the lumen, sodium is carried with it, along with water. In this type of diarrhea 
intestinal fluid secretion is isotonic with plasma even during fasting. It continues even 
when there is no oral food intake. 
 OSMOTIC 
Osmotic diarrhea occurs when too much water is drawn into the bowels. If a 
person drinks solutions with excessive sugar or excessive salt, these can draw water 
from the body into the bowel and cause osmotic diarrhea. Osmotic diarrhea can also 
be the result of maldigestion (e.g., pancreatic disease or Coeliac disease), in which the 
nutrients are left in the lumen to pull in water. Or it can be caused by 
osmotic laxatives (which work to alleviate constipation by drawing water into the 
bowels). In healthy individuals, too much magnesium or vitamin C or 
undigested lactose can produce osmotic diarrhea and distention of the bowel. A 
person who has lactose intolerance can have difficulty absorbing lactose after an 
extraordinarily high intake of dairy products. In persons who have fructose 
malabsorption, excess fructose intake can also cause diarrhea. High-fructose foods 
that also have a high glucose content are more absorbable and less likely to cause 
diarrhea. Sugar alcohols such as sorbitol (often found in sugar-free foods) are difficult 
for the body to absorb and, in large amounts, may lead to osmotic diarrhea.
[11]
 In most 
of these cases, osmotic diarrhea stops when offending agent (e.g. milk, sorbitol) is 
stopped. 
PRE CLINICAL STUDY OF PADIGALINGA CHENDURAM Page 38 
 
 EXUDATIVE 
Exudative diarrhea occurs with the presence of blood and pus in the stool. This 
occurs with inflammatory bowel diseases, such as Crohn's disease or ulcerative 
colitis, and other severe infections such as E. coli or other forms of food poisoning. 
 INFLAMMATORY 
Inflammatory diarrhea occurs when there is damage to the mucosal lining or 
brush border, which leads to a passive loss of protein-rich fluids and a decreased 
ability to absorb these lost fluids. Features of all three of the other types of 
diarrhea can be found in this type of diarrhea. It can be caused by bacterial infections, 
viral infections, parasitic infections, or autoimmune problems such as inflammatory 
bowel diseases. It can also be caused by tuberculosis, colon cancer, and enteritis. 
 DYSENTERY 
If there is blood visible in the stools, it is also known as dysentery. The blood 
is trace of an invasion of bowel tissue. Dysentery is a symptom of, among 
others, Shigella,Entamoeba histolytica, and Salmonella 
DEHYDRATION 
The most severe threat posed by diarrhoea is dehydration. During a diarrhoeal 
episode, water and electrolytes (sodium, chloride, potassium and bicarbonate) are lost 
through liquid stools, vomit, sweat, urine and breathing. Dehydration occurs when 
these losses are not replaced. 
The degree of dehydration is rated on a scale of three. 
1. Early dehydration – no signs or symptoms. 
2. Moderate dehydration: 
 thirst 
 restless or irritable behaviour 
 decreased skin elasticity 
 sunken eyes 
3. Severe dehydration: 
 symptoms become more severe 
 shock, with diminished consciousness, lack of urine output, cool, moist 
extremities, a rapid and feeble pulse, low or undetectable blood pressure, and pale 
skin. 
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Death can follow severe dehydration if body fluids and electrolytes are not 
replenished, either through the use of oral rehydration salts (ORS) solution, or through 
an intravenous drip. 
CAUSES 
 INFECTION: 
 Diarrhoea is a symptom of infections caused by a host of bacterial, viral and 
parasitic organisms, most of which are spread by faeces-contaminated water. Infection 
is more common when there is a shortage of adequate sanitation and hygiene and safe 
water for drinking, cooking and cleaning. Rotavirus and Escherichia coli are the two 
most common etiological agents of diarrhoea in developing countries. 
 
 MALNUTRITION:  
 Children who die from diarrhoea often suffer from underlying malnutrition, 
which makes them more vulnerable to diarrhoea. Each diarrhoeal episode, in turn, 
makes their malnutrition even worse. Diarrhoea is a leading cause of malnutrition in 
children under five years old. 
 
 SOURCE: 
 Water contaminated with human faeces, for example, from sewage, septic 
tanks and latrines, is of particular concern. Animal faeces also contain 
microorganisms that can cause diarrhoea. 
 
 OTHER CAUSES: 
 Diarrhoeal disease can also spread from person-to-person, aggravated by poor 
personal hygiene. Food is another major cause of diarrhoea when it is prepared or 
stored in unhygienic conditions. Water can contaminate food during irrigation. Fish 
and seafood from polluted water may also contribute to the disease. 
PATHOPHYSIOLOGY OF DIARRHEA 
Diarrhea is an increase in the volume of stool or frequency of defecation. It is 
one of the most common clinical signs of gastrointestinal disease, but also can reflect 
primary disorders outside of the digestive system. Certainly, disorders affecting either 
the small or large bowel can lead to diarrhea. 
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For many people, diarrhea represents an occasional inconvenience or 
annoyance, yet at least 2 million people in the world, mostly children, die from the 
consequences of diarrhea each year. 
There are numerous causes of diarrhea, but in almost all cases, this disorder is 
a manifestation of one of the four basic mechanisms described below. It is also 
common for more than one of the four mechanisms to be involved in the pathogenesis 
of a given case. 
 Osmotic Diarrhea 
Absorption of water in the intestines is dependent on adequate absorption of 
solutes. If excessive amounts of solutes are retained in the intestinal lumen, water will 
not be absorbed and diarrhea will result. Osmotic diarrhea typically results from one 
of two situations: 
 Ingestion of a poorly absorbed substrate: The offending molecule is usually a 
carbohydrate or divalent ion. Common examples include mannitol or sorbitol, 
epson salt (MgSO4) and some antacids (MgOH2). 
 Malabsorption: Inability to absorb certain carbohydrates is the most common 
deficit in this category of diarrhea, but it can result virtually any type of 
malabsorption. A common example of malabsorption, afflicting many adults 
humans and pets islactose intolerance resulting from a deficiency in the brush 
border enzyme lactase. In such cases, a moderate quantity of lactose is consumed 
(usually as milk), but the intestinal epithelium is deficient in lactase, and lactose 
cannot be effectively hydrolyzed into glucose and galactose for absorption. The 
osmotically-active lactose is retained in the intestinal lumen, where it "holds" 
water. To add insult to injury, the unabsorbed lactose passes into the large 
intestine where it is fermented by colonic bacteria, resulting in production of 
excessive gas. 
A distinguishing feature of osmotic diarrhea is that it stops after the patient is 
fasted or stops consuming the poorly absorbed solute. 
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 Secretory Diarrhea 
Large volumes of water are normally secreted into the small intestinal lumen, but 
a large majority of this water is efficienty absorbed before reaching the large intestine. 
Diarrhea occurs when secretion of water into the intestinal lumen exceeds absorption. 
Many millions of people have died of the secretory diarrhea associated with 
cholera. The responsible organism, Vibrio cholerae, produces cholera toxin, which 
strongly activates adenylyl cyclase, causing a prolonged increase in intracellular 
concentration of cyclic AMP within crypt enterocytes. This change results in 
prolonged opening of the chloride channels that are instrumental in secretion of water 
from the crypts, allowing uncontrolled secretion of water. Additionally, cholera toxin 
affects the enteric nervous system, resulting in an independent stimulus of secretion. 
Exposure to toxins from several other types of bacteria (e.g. E. coli heat-labile 
toxin) induces the same series of steps and massive secretory diarrhea that is often 
lethal unless the person or animal is aggressively treated to maintain hydration. 
In addition to bacterial toxins, a large number of other agents can induce secretory 
diarrhea by turning on the intestinal secretory machinery, including: 
 some laxatives 
 hormones secreted by certain types of tumors (e.g. vasoactive intestinal peptide) 
 a broad range of drugs (e.g. some types of asthma medications, antidepressants, 
cardiac drugs) 
 certain metals, organic toxins, and plant products (e.g. arsenic, insecticides, 
mushroom toxins, caffeine) 
In most cases, secretory diarrheas will not resolve during a 2-3 day fast. 
 Inflammatory and Infectious Diarrhea 
The epithelium of the digestive tube is protected from insult by a number of 
mechanisms constituting the gastrointestinal, but like many barriers, it can be 
breached. Disruption of the epithelium of the intestine due to microbial or viral 
pathogens is a very common cause of diarrhea in all species. Destruction of the 
epithelium results not only in exudation of serum and blood into the lumen but often 
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is associated with widespread destruction of absorptive epithelium. In such cases, 
absorption of water occurs very inefficiently and diarrhea results. Examples of 
pathogens frequently associated with infectious diarrhea include: 
 Bacteria: Salmonella, E. coli, Campylobacter 
 Viruses: rotaviruses, coronaviruses, parvoviruses (canine and feline), norovirus 
 Protozoa: coccidia species, Cryptosporium, Giardia 
The immune response to inflammatory conditions in the bowel contributes 
substantively to development of diarrhea. Activation of white blood cells leads them 
to secrete inflammatory mediators and cytokines which can stimulate secretion, in 
effect imposing a secretory component on top of an inflammatory diarrhea. Reactive 
oxygen species from leukocytes can damage or kill intestinal epithelial cells, which 
are replaced with immature cells that typically are deficient in the brush border 
enyzmes and transporters necessary for absorption of nutrients and water. In this way, 
components of an osmotic (malabsorption) diarrhea are added to the problem. 
 Diarrhea Associated with Deranged Motility 
In order for nutrients and water to be efficiently absorbed, the intestinal contents 
must be adequately exposed to the mucosal epithelium and retained long enough to 
allow absorption. Disorders in motility than accelerate transit time could decrease 
absorption, resulting in diarrhea even if the absorptive process per se was proceeding 
properly. 
Alterations in intestinal motility (usually increased propulsion) are observed in 
many types of diarrhea. What is not usually clear, and very difficult to demonstrate, is 
whether primary alterations in motility are actually the cause of diarrhea or simply an 
effect 
PREVENTION AND TREATMENT 
Key measures to prevent diarrhoea include: 
 access to safe drinking-water; 
 use of improved sanitation; 
 hand washing with soap; 
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 exclusive breastfeeding for the first six months of life; 
 good personal and food hygiene; 
 health education about how infections spread; and 
 rotavirus vaccination. 
Key measures to treat diarrhoea include the following: 
 Rehydration: with oral rehydration salts (ORS) solution. ORS is a mixture of 
clean water, salt and sugar. It costs a few cents per treatment. ORS is absorbed in 
the small intestine and replaces the water and electrolytes lost in the faeces. 
 Zinc supplements: zinc supplements reduce the duration of a diarrhoea episode by 
25% and are associated with a 30% reduction in stool volume. 
 Rehydration: with intravenous fluids in case of severe dehydration or shock. 
 Nutrient-rich foods: the vicious circle of malnutrition and diarrhoea can be broken 
by continuing to give nutrient-rich foods – including breast milk – during an 
episode, and by giving a nutritious diet – including exclusive breastfeeding for the 
first six months of life – to children when they are well. 
 Consulting a health professional, in particular for management of persistent 
diarrhoea or when there is blood in stool or if there are signs of dehydration. 
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4. MATERIALS AND METHODS 
 
Drug Selection:  
In this dissertation, the Padiga linga chenduram preparation was collected 
from Anuboga vaidya deva ragasiyam, part:4, Page: 407, edition year: 1991  
Ingredients: 
 padikaram (Alum) 
 Lingam (Cinnabar) 
Collection and Authentication of Ingredients: 
The raw drugs Lingam (Cinnabar), and padikaram (Alum) were purchased 
from authorized drug store in Nagarcoil at kanyakumari district. The raw materials 
were identified and authenticated by experts of PG Gunapadam department, 
Govt.Siddha Medical College, Palayamkottai, Tamilnadu. 
After identification, the samples of raw materials had been conserved in the 
laboratory of the department for future reference. 
 
Purification of Ingredients: 
One of the most important tasks is removal of the toxic substances, which is 
called purification (Suddhi) of raw materials by Siddhars. Otherwise it may result in 
toxicity. Suddhi contributes the following changes in the raw drug: 
 Reduction in particle size 
 Conjugation of trace elements 
 Elimination of unwanted elements 
 Formation of desirable compounds 
Purification of Lingam (Cinnabar), 
The mixture contains equal portion of lemon juice, cow‘s milk and aqeous 
extract of Acalypha (Kuppaimeni) and allowed to fuse cinnabar so as to get it in a 
consolidated potency state. 
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4.1.PREPARATION OF PADIGA LINGA CHENDURAM: 
Materials Required: 
 Purified cinnabar thathu (lingam) - 4.1g 
Alum  (padikaram)   - 35g 
Procedure: 
Setp 1: Take a mudpot place it on the gas stove 
Step 2 : Put the alum on to the mudpot and then gently increase heat and after 
few hours the  alum becomes the puffed alum. At the time of puffing of alumen, the 
powered, cinnabar is sprinkled over the alum. After the puffing of alum is completed. 
Then it is grinded in the mortar into powdered form. 
             Form of the medicine  : Chenduram (Powder) 
            Shelf –life   :  75 year 
            Indications                             :  Athisaaram (dysentery),  
Seetha baedi (Diarrhea with bloody flux), Perum kalichal (Persistent diarrhea). 
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4.2. STANDARDIZATION OF THE DRUG 
4.2.1. STANDARDIZATION AS PER SIDDHA 
CLASSICAL LITERATURE 
1. Colour: 
 Mostly Chendurams are pink and red in colour.  
 
2. Floating on Water:  
When a pinch of chenduram is sprinkled over the water in a glass container, it 
should partly floated & partly immersed.  
 
3. Finger Print Test: 
Well prepared chenduram should be very fine. When a pinch of chenduram is 
taken and rubbed in between the thumb and index finger. It should enter into the lines 
of the fingers. It confirmed the fineness of chenduram.    
 
4. Lustre: 
If any glowing particles are seen in the chenduram, it shows that the drug is 
not prepared properly and possesses unchanged substances like metals and other toxic 
substances. So, there should be no glowing particles present in the properly prepared 
chenduram.  
 
5. Taste: 
Properly prepared chenduram should be completely tasteless. If any taste is 
present in chenduram, it indicates the preparation was not well prepared. It needs 
another pudam (incineration) process.   
6. If the chenduram is put into a crucible and heated in a blower or oven, it should not 
revert to its metallic state. 
The final product is analysed as per Siddha classical standardization methods. 
Based on the results it was suitable for further analysis. 
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Standardization of Padiga linga chenduram By Using Modern Techniques: 
Owing to longstanding and time proven uses of herbo-mineral drug along with 
their safety margins, World Health Organisation (WHO) has taken necessary steps to 
ensure quality control with modern techniques and application of suitable standards 
for this purpose.Standardization of drug helps to authenticate and determine its quality 
and efficiency. Standardization of herbo mineral drug is rooted in qualitative and 
quantitative analysis by means of physico-chemical properties and instrumental 
analysis.   
 The physico-chemical analysis of Padiga linga chenduram was done in 
AravindhHerbalsLab (P)LTD 
 The chemical finger print was engaged by using modern analytical technique 
Fourier Transform Infra-Red Spectroscopy (FTIR).  
 The particle size and qualitative analysis of chemical elements of Padiga linga 
chenduram were also assessed by Scanning Electron Microscope . 
 The quantitative and qualitative analysis of chemical elements was carried out by 
using Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES). 
 
4.2.2. ORGANOLEPTIC CHARACTERS: 
Organoleptic properties are the aspects of drug as experienced by the senses, 
including taste, sight, smell, and touch. Organoleptic evaluation is also called 
morphological or macro scopical evaluation. It is a technique of quantitative 
evaluation based on study of morphological and sensory profile i.e. by colour, odour, 
taste, and size. 
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4.2.3.PHYSICO CHEMICAL ANALYSIS 
 
Ash Value: 
The Ash yielded by an organic compound measures the amount of Inorganic 
matter present as impurity. Ash values are helpful in determining the quality and 
purity of crude drugs in the powder form. Ash determination judges the identity and 
cleanliness of drugs and provides information regarding adulteration with inorganic 
matter
 
Determination of Total Ash Value: 
Total ash includes physiological ash, which is derived from the medicine and 
non-physiological, which is often from environment contaminations such as sand and 
soil.2 g of powdered drug was accurately weighed in a silica crucible which was 
previously ignited and weighed. The powdered drug was spread as a layer on the 
bottom of the crucible. It was then incinerated at a temperature not exceeding 450°C 
until free from carbon. The crucible was then cooled and weighed. The total ash value 
is recorded. 
Determination of Water Soluble Ash: 
 The ash obtained in the determination of total ash is boiled for 5minutes with 
25ml water. The insoluble ashes is collected using filter paper and washed with hot 
water and then transferred to the silica crucible then ignited for 15minutes at 
temperature not exceeding 450
o
C. The silica crucible and residue are weighed until 
constant weight is attained for determination of weight of insoluble ash. The weight of 
the water soluble ash is determined by subtracting the weight of insoluble ash from 
the weight of total ash. 
 
Determination of Acid Insoluble Ash: 
Total ash content alone is not sufficient to reflect the quality, thus the acid 
insoluble ash of the drug is quite important. The ash obtained in the determination of 
total ash, was boiled with 25 ml 10%Hcl for 5 minutes and the insoluble ash was 
collected in a clean filter paper and washed with hot water. The insoluble ash was 
then transferred to a pre weighed silica crucible, ignited for 5 minutes at a temperature 
not exceeding 450
0
 C, and then it is cooled and weighed. The results are recorded. 
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Loss on Drying: 
Loss on drying is the loss in percentage w/w resulting from water and volatile 
matter of any kind that can be driven off under a specified condition. Moisture is one 
of the major factors responsible for the deterioration of the drugs and formulations. 
Low moisture content is always desirable for higher stability of drugs 
 Determination of Loss on Drying(Normal range: 5%-8%) 
 A glass stopper and a shallow weighing bottle were weighed accurately and 
the quantity of the sample as specified was transferred to the bottle covered and 
weighed. The sample was distributed evenly and the bottle was placed in the drying 
chamber. The sample was then dried for a specific period of time, and the bottle was 
removed from the chamber and allowed to cool at room temperature in desiccators 
before weighing. The percentage loss on drying is calculated. The acceptable range is 
5%–8%. 
Solubility:  
A pinch of the sample was taken in a dry test tube and shaken well with 
distilled water.    
A little amount of the sample is shaken well with con HCl and then 
Con.H2SO4. Test sample Solubility was observed.  
PH Value: 
Potentiometrically pH value was determined by a glass electrode and a 
suitable pH meter. The pH of the KSK tablet was written in results column. 
Thin-Layer Chromatography (TLC): 
Thin-layer chromatography is a technique in which a solute undergoes 
distribution between two phases, a stationary phase acting through adsorption and a 
mobile phase in the form of a liquid. The adsorbent is a relatively thin, uniform layer 
of dry finely powdered material applied to a glass, plastic or metal sheet or plate. 
Glass plates are most commonly used. Separation may also be achieved on the basis 
of partition or a combination of partition and adsorption, depending on the particular 
type of support, its preparation and its use with different solvent.  
Identification can be effected by observation of spots of identical RF value and about 
equal magnitude obtained, respectively, with an unknown and a reference sample 
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chromatographed on the same plate. A visual comparison of the size and intensity of 
the spots usually serves for semi-quantitative estimation. 
 
Uses of Thin-Layer Chromatography: 
1. To determine the number of components in a mixture. 
2. To determine the identity of two substances. 
3. To monitor the progress of a reaction. 
4. To determine the effectiveness of a purification. 
 
Apparatus: 
Flat glass plates of appropriate dimensions which allow the application at 
specified points of the necessary quantities of the solution being examined and 
appropriate reference solutions and which allow accommodation of the specified 
migration path-length. The plates are prepared as described below; alternatively, 
commercially prepared plates may be used.An aligning tray or a flat surface on which 
the plates can be aligned and rested when the coating substance is applied. 
The adsorbent or coating substance consisting of finely divided adsorbent materials, 
normally 5 µm to 40 µm in diameter, is suitable for chromatography. It can be applied 
directly to the plate or can be bonded to the plate by means of Plaster of Paris 
(Hydrated Calcium Sulphate) or with any other suitable binders. The adsorbent may 
contain fluorescing material to help in visualising spots that absorb ultra-violet light.A 
spreader which, when moved over the glass plate, will apply a uniform layer of 
adsorbent of desired thickness over the entire surface of the plate.A storage rack is 
used to support the plates during drying and transportation. 
  
A developing chamber can accommodate one or more plates and can be 
properly closed and sealed. The chamber is fitted with a plate support rack that 
supports the plates, back to back, with lid of the chamber in place.Graduated micro-
pipettes capable of delivering microlitre quantities say 10 µl and less.  
 
A reagent sprayer that will emit a fine spray and will not itself be attacked by 
the reagent.An ultra-violet light, suitable for observation at short (254 nm) and long 
(365 nm) ultra-violet wavelengths. 
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Preparation of Plates: 
  The plates are prepared in the following manner, unless otherwise specified in 
the monograph. Prepare a suspension of the coating substance in accordance with the 
instructions of the supplier and, using the spreading device designed for the purpose, 
spread a uniform layer of the suspension, 0.25 to 0.30 mm thick, on a flat glass plate 
20 cm long. Allow the coated plates to dry in air, heat at 100º to 105º for at least 1 
hour (except in the case of plates prepared with cellulose when heating for 10 minutes 
is normally sufficient) and allow cooling, protected from moisture. Store the plates 
protected from moisture and use within 3 days of preparation. At the time of use, dry 
the plates again, if necessary, as prescribed in the monographs. 
 
Method: 
Unless unsaturated conditions are prescribed, prepare the tank by lining the 
walls with sheets of filter paper; pour into the tank, saturating the filter paper in the 
process, sufficient of the mobile phase to form a layer of solvent 5 to 10 mm deep, 
close the tank and allow it to stand for 1 hour at room temperature. Remove a narrow 
strip of the coating substance, about 5 mm wide, from the vertical sides of the plate. 
Apply the solutions being examined in the form of circular spots about 2 to 6 mm in 
diameter, or in the form of bands (10 to 20 mm x 2 to 6 mm unless otherwise 
specified) on a line parallel with, and 20 mm from, one end of the plate, and not 
nearer than 20 mm to the sides; the spots should be 15 mm apart. If necessary, the 
solutions may be applied in portions, drying between applications. Mark the sides of 
the plate 15 cm, or the distance specified in the monograph, from the starting line. 
Allow the solvent to evaporate and place the plate in the tank, ensuring that it is as 
nearly vertical as possible and that the spots or bands are above the level of the mobile 
phase. Close the tank and allow to stand at room temperature, until the mobile phase 
has ascended to the marked line. Remove the plate and dry and visualise as directed in 
the monograph; where a spraying technique is prescribed it is essential that the 
reagent be evenly applied as a fine spray. For two-dimensional chromatography dry 
the plate after the first development and carry out the second development in a 
direction perpendicular to the first. When the method prescribed in the monograph 
specified ‗protected from light‘ or ‗in subdued light‘ it is intended that the entire 
procedure is carried out under these conditions. 
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Visualization: 
The phrases ultra-violet light (254 nm) and ultra-violet light (365 nm) indicate that the 
plate should be examined under an ultra-violet light having a maximum output at 
about 254 or at about 365 nm, as the case may be. 
The term secondary spot means any spot other than the principal spot. Similarly, a 
secondary band is any band other than the principal band. 
 
Rf. Value: 
Measure and record the distance of each spot from the point of its application and 
calculate Rf. value by dividing the distance travelled by the spots by the distance 
travelled by the front of the mobile phase. 
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4.2.4. CHEMICAL ANALYSIS 
 
 In the qualitative analysis procedure, the chemical properties of an unknown 
substance are determined by systematically reacting the unknown with a number of 
different reagents. By predetermining what the particular reaction will produce if a 
specific ion is present, the ions that actually are in the solution can be identified. 
 
Preparation of the Extract: 
  100 mg of Padiga linga chenduram is weighed accurately and placed into a 
clean beaker and added a few drops of conc.Hydrochloric acid and is evaporated 
well.After evaporation the content is cooled and added a few drops of conc.nitric acid 
and evaporated.After cooling, the content is dissolved in 20ml of distilled water.It is 
then transferred to 100ml volumetric flask and made-up to 100ml with distilled water 
and is mixed well.It is filtered and is used for analysis. 
Test for Basic and Acidic Radicals: 
1. Test for Calcium: 
When 2ml of the above prepared extract is taken in a clean test tube. To this 
add 2 ml of 4% ammonium oxalate solution. No white precipitate is formed. It  
indicates the absence of calcium  
2. Test for Sulphate: 
2ml of the extract is added to 5% Barium chloride solution.A white precipitate 
is formed. It indicates the presence of sulphate. 
3. Test for Chloride: 
The extract is treated with silver nitrate solution. A white precipitate is 
formed. It indicates the presence of chloride 
4. Test for Carbonate: 
The substance is treated with concentrated Hcl. No Brisk effervescence is 
formed. It indicates the absence of carbonate 
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5.Test for Starch: 
The extract is added with weak iodine solution. No blue colour is formed. It 
indicates the absence of starch 
6. Test for Ferric Iron: 
The extract is acidified with glacial acetic acid and potassium ferrocyanide. 
Blue colour is formed. It indicates the presence of Ferric Iron 
7. Test for Ferrous Iron: 
The extract is treated with concentrated nitric acid and ammonium 
thiocyanatesolution. Blood red colour is formed. It indicates the presence of Ferrous 
Iron. 
8. Test for Phosphate: 
The extract is treated with ammonium molybdate and concentrated nitric acid. 
No yellow precipitate is formed. It indicates the absence of Phosphate. 
9.Test for Albumin: 
The extract is treated with Esbach‘s reagent. No yellow precipitate is formed. 
It indicates the absence of Albumin. 
10.Test for Tannic Acid: 
The extract is treated with ferric chloride. No blue black precipitate is formed. 
It indicates the absence of Tannic Acid. 
11.Test for Unsaturated Compounds: 
Potassium permanganate solution is added to the extract. It does not get 
decolourised. It indicates the absence of Unsaturated Compounds. 
 
12.Test for The Reduicing Sugar: 
5ml of Benedict‘s qualitative solution is taken in a test tube and allowed to 
boil for 2 mins and add 8-10 drops of the extract and again boil it for 2 mins. No 
colour change occurs. It indicates the absence of Reduicing sugar. 
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13.Test for Amino Acid: 
One or two drops of the extract is placed on a filter paper and dried well .After 
drying, 1% Ninnhydrin is sprayed over the same and dried  well. No violet colour is 
formed. It indicates the absence of Amino acid. 
14.Test for  Zinc: 
The extract is treated with potassium Ferro cyanide. No white precipitate is 
formed. It indicates the absence of Zinc. 
15.Test for Mercury 
The extract is treated with ammonia and boil (till the ammonia cases off) and 
then potassium Iodide (1% solution) is added. No scarlet precipitate is formed. It 
indicates the absence of Mercury 
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4.2.5.INSTRUMENTAL ANALYSIS 
4.2.5.1.SCANNING ELECTRON MICROSCOPE (SEM) 
 
The microstructure of the powders was examined using a Hitachi S 3000H scanning electron microscope  
 
Introduction: 
 
The scanning Electron Microscope is one of the most versatile instruments 
available for the examination and analysis of the micro structural characteristics of 
solid objects. The primary reason for the SEM‘s usefulness is the high resolution 
which can be obtained when bulk objects are examined; values of the order of 5nm 
(50degreeA) are usually quoted for commercial instruments. Advanced research 
instruments have been described which have achieved resolutions of about 2.5nm (25 
degree A). Any solid material can be studied. Sample size is limited to specimens less 
than about 10µm in diameter 
 
Principle:  
The beam is then rastered over the specimen in synchronism with the beam of 
a cathode ray tube display screen. The eleastically scattered secondary electrons are 
emitted from the sample surface and collected by a scintillator, the signal from which 
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is used to modulate the brightness of the cathode ray tube. In this way the secondary 
electron emission from the sample is used to form an image on the CRT display 
screen. (Goldstein, et. al., 1992) 
 
 
 
 
 
SEM MECHANISM 
 
 
Procedure: 
An electron beam passing through an evacuated column is focused by 
electromagnetic lenses onto the specimen surface. Since an electron is a charged 
particle, it has a strong interaction with the specimen (due to coulomb interaction).So 
when an electron beam images on a specimen, it is scattered by atomic layers near the 
surface of the specimen. As a result, the direction of electron motion changes and its 
energy is partially lost. Once an incident electron (primary electron) enters a 
substance, its direction of motion is influenced by various obstructions (multiple 
scattering), and follows a complicated trajectory which is far from a straight line. 
Also, when electrons with the same energy are incident on the specimen surface, a 
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portion of electrons is reflected in the opposite direction (back scattered) and the 
remainder is absorbed by the specimen (exciting X- rays or other quanta in the 
process). If the specimen issufficiently thin, the electron can pass all the way through 
the specimen (transmitted electrons, scattered or non-scattered). 
The depth at which various signals are generated due to electron beam – 
specimen interaction indicates the diffusion area of the signals in the specimen in 
addition to the local chemistry of the specimen. Secondary electrons mainly indicate 
information about the surface of a specimen. Since secondary electrons do not diffuse 
much inside the specimen, they are most suitable for observing the fine-structures of 
the specimen surface. That is to say, sharp scanning images with high resolution can 
be expected from secondary electrons, because of the smaller influence on resolution 
by their diffusion.  
 
As the incident electron energy increases, the probability of incident electrons 
Colliding with elemental components of the specimen and releasing secondary 
electrons also increases. In other words, as the incident energy increases, the emission 
of electrons from the specimen also increases. However, as the energy increases 
beyond a certain level, the incident electrons penetrate deeper into the specimen with 
the result that the specimen derived electrons use up most of their energy to reach the 
specimen surface. Consequently, the electron emission yield decreases. Therefore, the 
peak secondary electron emission yield occurs at a specific entry level of the incident 
electrons. 
 
In order to verify the existence of a substance and recognize its shape, the 
image contrast must be well defined. In other words, even if a system boasts 
extremely high resolution, if image contrast is poor, it would be extremely difficult to 
determine the existence of a substance, let alone recognize its shape. Another 
important feature of the SEM is the three-dimensional appearance of the specimen 
image, which is a direct result of the large depth of field.  
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Applications: 
The SEM is capable of examining objects at very low magnification. This 
feature is useful in viewing particle size and shape of any composition at various 
stages of preparation in Siddha system as well as other fields.The large depth of field 
available in the SEM makes it possible to observe 3-dimensional objects in stereo. 
Today, a majority of SEM facilities are equipped with X-ray analytical capabilities. 
Thus topographic crystallographic and compositional information can be obtained 
rapidly, efficiently and simultaneously from the same area. 
 
The author was chosen this analysis for detecting Particle size of the classical 
Siddha mineral drug PADIGALINGA CHENDURAM. SEM results of PADIGALINGA 
CHENDURAM were represented in results section. 
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4.2.5.2.FOURIER TRANSFORM-INFRA RED SPECTROSCOPY 
(FT-IR) 
 
 
Introduction: 
Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular structure .The spectral bands can be assigned to different vibrational modes 
of the molecule. The various functional groups present in the molecule can be 
assigned by a comparison of the spectra with characteristic functional group 
frequencies. As the positions of the bands are directly related to the strength of the 
chemical bond, a large number of investigations including intermolecular interactions, 
phase transitions and chemical kinetics can be carried out using this branch of 
spectroscopy. In IR spectroscopy, the resonance absorption is made possible by the 
change in dipole moment accompanying the vibrational transition. The Infrared 
spectrum originates from the vibrational motion of the molecule. The vibrational 
frequencies are a kind of fingerprint of the compounds. This property is used for 
characterization of organic, inorganic and biological compounds. The band intensities 
are proportional to the concentration of the compound and hence qualitative 
estimations are possible. The IR spectroscopy is carried out by using Fourier 
transform technique.  
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Principle: 
Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation characteristic 
of the interacting system may be absorbed (or emitted). The experimental data consist 
of the nature (frequency of wave length) and the amount (intensity) of the 
characteristic radiation absorbed or emitted. These data are correlated with the 
molecular and electronic structure of the substance and with intra- and inter molecular 
interactions. 
Source   : Nernst Glower 
Beam splitter  :  It is made up of a transparent material. Thin films of  
Silicondepositedon  Potassium bromide (KBr)   
Bromide (KBr) Detectors:  DeutratedTriGlycine 
Sulphate (DTGS). 
Scan Range  :  MIR 450to 4000 cm-1 
Resolution  :   4.0 cm-1 
Sample required : 50mg, solid or liquid 
Sampling Techniques: There are a variety of techniques for sample preparation  
physical form of the sample to be analyzed. 
Solid   : KBr or Nujol mull method. 
Liquid   : Csl / TIBr Cells 
Gas   : Gas cells 
 
Measurements Techniques: 
The procedure for recording the %T or %A is as follows: 
 Air is first scanned for the reference and stored. The sample is then recorded 
andfinally the ratio of the sample and reference data is computed to give required 
%T     or %A at various frequencies. 
 Study of substances with strong absorbance bands and weak absorbance bands 
aswell as possible. 
 Small amount of samples are sufficient 
 High resolution is obtained. 
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Procedure: 
Typically,1.5 mg of protein, dissolved in the buffer used for its purification, were 
centrifuged in a 30 K Centric on micro concentrator (Amicon) at 3000_g at 4oC until 
a volume of approximately 40 Al. 
 
 Then, 300 Al of 20 mm buffer, prepared in H20 or 2H20, pH or p2H 7.2, were 
added and the sample concentrated again. The p2H value corresponds to the pH 
meter reading + 0.4. The concentration and dilution procedure was repeated 
several times in order to completely replace the original buffer with the Tris 
buffer. 
 
 The washings took 24 h, which is the time of contact of the protein with the 2H20 
medium prior FT-IR analysis. In the last washing, the protein was concentrated to 
fine a volume of approximately 40 Al and used for the infrared measurements. 
The concentrated protein sample was placed in CaF2 windows and a 6 Am tin 
spacer or a 25 Am Teflon spacer for the experiments in H2O or 2H2O, 
respectively. FT-IR spectra were recorded by means of a Perkin-Elmer -Spectrum-
1 FT-IR spectrometer using a deuteratedtriglycinesulfate detector. 
 
 At least 24 h before, and during data acquisition, the spectrometer were 
continuously purged with dry air at a dew point of 40
o
C. Spectra of buffers and 
samples were acquired at 2 cm_1 resolution under the same scanning and 
temperature conditions. In the thermal denaturation experiments, the temperature 
was raised in 5
o
C steps from 20 to 95
o
C. 
 
 Before spectrum acquisition, samples were maintained at the desired temperature 
for the time necessary for the stabilization of temperature inside the cell (6 
min).Spectra were collected and processed using the SPECTRUM software from 
Perkin-Elmer. Correct subtraction of H20 was judged to yield an approximately 
flat baseline at 1900-1400 cm_ 1, and subtraction of 2H20 was adjusted to the 
removal of the2H20 bending absorption close to 1220 cm_ 1 
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KBr Method 
 The sample is grounded using an agate mortar and pestle to give a very fine 
powder. 
 The finely powder sample is then mixed with about 100mg dried KBr salt. 
 The mixture is then pressed under hydraulic press using a die to yield a 
transparent disc and measure about 13mm diameter and 0.3mm in thickness. 
 
Nujol Mull Method: 
 The sample is ground using an agate mortar and pestle to give a very fine powder. 
 A small amount is then mixed with nujol oil to give a paste and this paste is 
thenapplied between two sodium chloride plates. 
 The plates are then placed in the instrument sample holder ready for scanning. 
 
Liquids: 
 Viscous liquids can be smeared in the cell and directly measured. 
 For dilute solutions, liquid cells and variable path length cells are employed. 
 
Applications: 
 Infrared spectrum is useful in identifying the functional groups like -OH, -
CN, -CO, -CH, -NH2, etc. Also quantitative estimation is possible in certain cases for 
chemicals, pharmaceuticals, petroleum products, etc. Resins from industries, water 
and rubber samples can be analyzed.  
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Mechanism analyser  
 
Analytical Capabilities: 
 Identifies chemical bond functional groups by the absorption of infrared radiation 
which excites vibrational modes in the bond. 
 Especially capable of identifying the chemical bonds of organic materials  
 Detects and identifies organic contaminants. 
 Identifies water, phosphates, sulphates, nitrates, nitrites, and ammonium ions  
 Detection limits vary greatly, but are sometimes <10
13
 bonds/cm
3
 or sometimes 
sub monolayer .Useful with solids, liquids, or gases. 
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4.2.5.3.INDUCTIVELY COUPLED PLASMA OPTICAL 
EMISSION SPECTROMETRY(ICP-OES): 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction: 
Inductively coupled plasma optical emission spectrometry (ICP-OES) is an 
analytical technique used for the detection of trace metals. It is a type of emission 
spectroscopy that uses the inductively coupled plasma to produce excited atoms and 
ions that emit electromagnetic radiation at wavelengths characteristic of a particular 
element. The intensity of this emission is indicative of the concentration of the 
element within the sample. 
 
Mechanism: 
The ICP-OES is composed of two parts:  ICP and the optical spectrometer. 
The ICP torch consists of 3 concentric quartz glass tubes. The output or ―work‖ coil 
of the radiofrequency (RF) generator surrounds part of this quartz torch. Argon gas is 
typically used to create the plasma. 
When the torch is turned on, an intense electromagnetic field is created within 
the coil by the high power radio frequency signal flowing in the coil. This RF signal is 
created by the RF generator which is, effectively, a high power radio transmitter 
driving the ―work coil‖ the same way a typical radio transmitter drives a transmitting 
antenna. The argon gas flowing through the torch is ignited with a Tesla unit that 
PRE CLINICAL STUDY OF PADIGALINGA CHENDURAM Page 66 
 
creates a brief discharge arc through the argon flow to initiate the ionization process. 
Once the plasma is ―ignited‖, the Tesla unit is turned off. 
The argon gas is ionized in the intense electromagnetic field and flows in a 
particular rotationally symmetrical pattern towards the magnetic field of the RF coil. 
Stable, high temperature plasma of about 7000 K is then generated as the result of the 
inelastic collisions created between the neutral argon atoms and the charged particles. 
A peristaltic pump delivers an aqueous or organic sample into a nebulizer where it is 
changed into mist and introduced directly inside the plasma flame. The sample 
immediately collides with the electrons and charged ions in the plasma and is itself 
broken down into charged ions. The various molecules break up into their respective 
atoms which then lose electrons and recombine repeatedly in the plasma, giving off 
radiation at the characteristic wavelengths of the elements involved. 
Within the optical chamber(s), after the light is separated into its different 
wavelengths (colours), the light intensity is measured with a photomultiplier tube or 
tubes physically positioned to ―view‖ the specific wavelength(s) for each element line 
involved, or, in more modern units, the separated colours fall upon an array of 
semiconductor photo detectors such as charge coupled devices (CCDs). In units using 
these detector arrays, the intensities of all wavelengths (within the system‘s range) 
can be measured simultaneously, allowing the instrument to analyse for every element 
to which the unit is sensitive all at once. Thus, samples can be analysed very quickly. 
The intensity of each line is then compared to previously measured intensities 
ofknown concentrations of the elements and their concentrations are then computed 
by interpolation along the calibration lines. In addition, special software generally 
corrects for  
interferences caused by the presence of different elements within a given 
sample matrix.  
 
Applications : 
ICP-OES is used in   the determination of metals, arsenic present in 
Traditional medicines, and trace elements bound to proteins. ICP-OES is widely used 
in minerals processing to provide the data on grades of various streams, for the 
construction of mass balances. 
The author used it for elemental identification and quantitative compositional 
information of the PADIGA LINGA CHENDURAM. 
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4.3.TOXICOLOGICAL STUDY  
4.3.1.ACUTE TOXICITY STUDY IN FEMALE WISTER 
RATS TO EVALUATE TOXICITY PROFILE OF 
PADIGALINGACHENDURAM 
 
OBJECTIVES 
 
The aim of this Study is to evaluate the toxicity of the test substance PADIGA 
LINGA CHENDURAM, when administered orally to Female Wister Rats with 
different doses, so as to provide a rational base for the evaluation of the toxicological 
risk to man and indicate potential target organs. 
Guidelines followed: 
 
(a)  OECD Guidelines No. 423, 
Study Design and Controls: 
 
1) Female Wister Rats in controlled age and body weight were selected. 
 
2) PADIGA LINGA CHENDURAM was administered at 5  mg/kg, 50  mg/kg, 300  
mg/kg, 1000  mg/kg, and  2000  mg/kg body weight as  (Water) as suspension along 
with blank. 
3) The results were recorded on day 0, with single oral dosing period of 14 days.  
 
EXPERIMENTAL PROCEDURE 
 
1. ANIMALS  
 
1.1. Supply 
 
        A total of 15 Female Wister Rats with an approximate age of 6 weeks and 
purchased from M/s.Venkateshwara Enterprises  Pvt. Ltd, Bangalore. On their arrival 
a sample of animals was chosen at random and weighed to ensure compliance with 
the age requested. The mean weights of Female Wister Rats were 100-150 g 
respectively.  The animals were housed in metabolic cages (55 x 32.7 x 19 cm), with 
sawdust litter, in such a way that each cage contained a maximum of 3 animals of the 
same sex. 
All animals underwent a period of 20 days of observation and acclimatization 
between the date of arrival and the start of treatment. During the course of this period, 
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the animals were inspected by a veterinary surgeon to ensure that they fulfilled the 
health requirements necessary for initiation of the Study. 
1.2. Housing 
 
The Female Wister Rats were housed in metabolic cages (55 x 32.7 x 19 cm), 
placed on racks. From the week before initiation of the treatment, each cage contained 
a maximum of 6 mice of the same sex and treatment group. 
Each cage was identified by a card, color coded according to the dose level. 
This card stated the cage number, number and sex of the animals it contained, Study 
number, test substance code, administration route, dose level and Study Director's 
name, date of the arrival of the animals and initiation of treatment. 
The temperature and relative humidity were continuously monitored. Lighting 
was controlled to supply 12 hours of light (7:00 to 19:00 hours) and 12 hours of dark 
for each 24-hour period. 
The cages corresponding to each experimental group were distributed on racks 
in such a manner that external factors, such as environmental conditions, were 
balanced as far as possible. 
 
2. DIET 
   All the rats had free access to a pelleted rat diet. The diet was analyzed by 
the   manufacturer to check its composition and to detect possible contaminants. 
2.1. Water 
 
The water was offered ad libitum in bottles.  
 
3. ADMINISTRATION ROUTE AND PROCEDURE 
 
          The test substance was administered orally. The Female Wister Rats belonging 
to the control group were treated with the vehicle (Water) at the same administration 
volume as the rest of the treatment groups. 
 
3.1 Numbering and Identification 
 
The animals were marked on body with picric acid solution prepared in water. 
The marking within the cage was as below. 
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                                   Table-1 Numbering and Identification 
 
 
                            
 
 
The group no., cage no., sex of the animal and animal no. were identified as 
indicated below using cage label and body marking on the animals 
 
Table-2 Numbering and Identification 
 
 
 
 
 
 
 
 
 
 
3.2 Doses 
The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighed and then 
drug was administered orally as single dose using a needle fitted onto a disposable 
syringe of approximate size at the following different doses. 
 
Table-3 Doses 
 
 
 
                                            
 
 
 
Group No Animal Marking 
1 Head 
2 Body 
3 Tail 
Cage No Group No Animal Marking Sex 
1 I H,B,T Female 
2 II H,B,T Female 
3 III H,B,T Female 
4 IV H,B,T Female 
5 V H,B,T Female 
GROUP DOSE 
Group-I 5  mg/kg 
Group-II 50  mg/kg 
Group-III 300  mg/kg 
Group-IV 1000  mg/kg 
Group-V 2000  mg/kg 
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The test item was administered as single dose. After single dose administration 
period, all animals were observed for day 14. 
 
Dose Preparation 
PADIGALINGACHENDURAM was added in distilled water and completely 
dissolved to form oral for administration. The dose was prepared of a required 
concentration before dosing by dissolving, in distilled water. It was mixed well. The 
preparation for different doses was vary in concentrations to allow a constant dosage 
volume. 
 
3.3 Administration 
The test item was administered orally to each Female Wister rats as single 
dose using a needle fitted onto a disposable syringe of appropriate size at the 
following different doses. The concentration was adjusted according to its body 
weight. The volume was not exceeding 10 ml/kg bodyweight. Variability in test 
volume was minimized by adjusting the concentration to ensure a constant volume at 
all dose levels. 
 
3.4 Observation period 
All animals were observed for any abnormal clinical signs and behavioral 
changes. The appearance, change and disappearance of these clinical signs, if any, 
were recorded for approximately 1.0, 3.0 and 4.0 hours post-dose on day of dosing 
and once daily thereafter for14 days. Animals in pain or showing severe signs of 
distress were humanely killed. The cageside observation was included changes in 
skin, fur, eyes and mucous membranes, occurrence of secretions and excretions. 
Autonomic activity like lacrimation,  piloerection, pupil size and unusual respiratory 
pattern, changes in gait, posture, response to handling, presence of clonic or tonic 
movements, stereotypes like excessive grooming and repetitive circling or bizarre 
behavior like self-mutilation, walking backwards etc were observed. At the 14th day, 
sensory reactivity to stimuli of different types (e.g. auditory, visual and proprioceptive 
stimuli) was conducted. Auditory stimuli responses were measured by clicker sound 
from approximately 30 cm to the rats; visual stimuli response were measured with the 
help of shining pen light in the eye of rats and placing a blunt object near to the eye of 
rats. Response to proprioceptive stimuli was measured by placing anterior/dorsal 
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surface of animals paw to the table edge. The responses of reactions for these three 
exercises were normal in animals belonging to both the controls as well as drug 
treatment dose groups. 
 
 
4 Mortality and Morbidity 
All animals were observed daily once for mortality and morbidity at 
approximately 1.0, 3.0 and 4.0 hours post dose on day of dosing and twice daily 
(morning and afternoon) thereafter for 14 days. 
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4.3.2.SUB ACUTE TOXICITY STUDY 
 
SUB-ACUTE TOXICITY STUDY IN WISTER RATS TO 
EVALUATE TOXICITY PROFILE OF PADIGA LINGA 
CHENDURAM  
 
1. Objective 
The objective of this ‗Sub-Acute Toxicity Study of PADIGA LINGA 
CHENDURAM   on Wister Rats‘ was to assess the toxicological profile of the test 
item when treated as a single dose. Animals should be observed for 28 days after the 
drug administration. This study provides information on the possible health hazards 
likely to arise from exposure over a relatively limited period of time.  
2. Test Guideline Followed 
      OECD 407 Method - Sub-Acute Toxic Class Method (Repeated Dose 28-Day 
Oral Toxicity Study in Rodents) 
3. Test Item Detail 
Name: PADIGALINGACHENDURAM  
 
4. Test System Detail 
The study was conducted on 5 male 5 female Wister rats. These   animals were 
selected because of the recommended rodent species for oral studies as per followed 
guideline and availability of Animals 8-12 weeks old male and female rats were 
selected after physical and behavioral examination. The body weight range was fallen 
within ± 20% of the mean body weight at the time of Randomization and grouping. 
The rats were housed in standard laboratory condition in Polypropylene cages, 
provided with food and water adlibitum in the Animal at M/s. Sree Venkateshwara 
Enterprises Pvt. Ltd, Bangalore. The experimental protocol was approved by 
Institutional Animal Ethical Committee as per the guidance of Committee for the 
Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry 
of Environment and Forest, government of India. 
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5.  Acclimatization 
The animals were selected after veterinary examination by the veterinarian. 
All the selected animals were kept under acclimatization for a week. 
6.  Randomization & grouping 
One day before the initiation of treatment (days 0- last day of acclimatization), 
the selected animals were randomly grouped into three different groups containing 
minimum 6 male animals per group.  
 
7.  Numbering and Identification 
The animals were marked on body with picric acid solution prepared in water. 
The marking within the cage was as below. 
 
        Table-1 Numbering and Identification 
 
 
 
 
 
 
 
Group No Animal Marking 
1. CONTROL H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
2. LOW DOSE OF  
PADIGALINGACHENDURAM  
300mg/kg. 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
3. MIDDLEDOSE OF 
PADIGALINGACHENDURAM  
600mg/kg. 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
4. HIGH DOSE OF  
PADIGALINGACHENDURAM  
900mg/kg. 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
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The group  no., cage no., sex of the animal and animal no. were identified  as 
indicated below  using cage  label and body marking on the animals: 
 
8.Husbandry 
8.1 Housing 
The Wister rats were housed in standard polypropylene cages with stainless 
steel top grill. Paddy husk was used as bedding. The paddy husk was changed at least 
twice in a week. From the week before   initiation of the treatment, each cage 
contained a maximum of 6 mice of the same sex and treatment group. 
 
 
8.2 Environmental conditions 
The animals were kept in a clean environment with 12 hour light and 12 hour 
dark cycles. The air was conditioned at 22±3
0
C and the relative humidity was 
maintained between 30-70% with 100% exhaust facility. The cages corresponding to 
each experimental group were distributed on racks in such a manner that external 
factors, such as environmental conditions, were balanced as far as possible. 
 
 
Cage 
No 
Group No Animal 
Marking 
Sex 
1 1. CONTROL                   
H,B,T,HB,NM                  
H,B,T,HB, NM 
 
 
Male 
Female 
2 2. LOW DOSE OF  
PADIGALINGACHENDURAM  
300mg/kg. 
                  
H,B,T,HB,NM                   
H,B,T,HB, NM  
 
Male 
Female 
3 3. MIDDLEDOSE OF 
PADIGALINGACHENDURAM  
600mg/kg. 
                  
H,B,T,HB,NM                   
H,B,T,HB, NM 
 
 
Male 
Female 
4 4. HIGH DOSE OF  
PADIGALINGACHENDURAM  
900mg/kg. 
                  
H,B,T,HB,NM                   
H,B,T,HB ,NM  
 
Male 
Female 
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8.3 Feed & feeding schedule 
‗Sai Durga Animal Feed, Bangalore. Feed was provided adlibitum throughout 
the study period, except over night fasting (18-20 hours) prior to dose administration. 
After the substance has been administered, food was with held for a further 3-4 hours. 
8.4 Water 
The water was offered adlibitum in bottles. There was periodically analyzed to 
detect the presence of possible contaminants 
8.5 Doses 
The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighed and then 
extract was administered orally as single dose using a needle fitted on to a disposable 
syringe of approximate size at the following different doses. 
Table-2 Dose level 
 
The test item was administered as single dose. After single dose administration 
period, all animals were observed for 28 days. 
 
 
 
 
TEST 
GROUP 
 
DOSE TO ANIMALS 
(mg/kg body-weight/day) 
 
NUMBER OFANIMALS 
Group-1 1. CONTROL 10 (5MALE and5 FEMALE) 
Group-II 2. LOW DOSE OF  PC  300mg/kg. 10(5MALE and 5 FEMALE) 
 
Group-III 3. MIDDLEDOSE OF  PC  600mg/kg. 10(5MALE and 5 FEMALE) 
Group-IV 4. HIGH DOSE OF   PC  900mg/kg. 10(5MALE and 5 FEMALE) 
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Dose Preparation 
PADIGA LINGA CHENDURAM was added in distilled water and 
completely dissolved to for oral for administration. The dose was prepared of a 
required concentration before dosing by dissolving PADIGA LINGA 
CHENDURAM in distilled water. It was mixed well. The preparation for different 
doses was vary in concentrations to allow a constant dosage volume. 
 
8.6 Administration 
The test item was administered orally to each   rat as single dose using a 
needle fitted on to a disposable syringe of appropriate size at the following different 
doses. The concentration was adjusted according to its body weight. The volume was 
not exceeding 10 ml/kg body weight. Variability in test volume was minimized by 
adjusting the concentration to ensure a constant volume at all dose levels. 
 
9. OBSERVATIONS  
These observations were also performed on week-ends. The observations 
included   but were not limited to changes in skin and fur, in the eyes and mucous 
membranes, in the respiratory, circulatory, central nervous and autonomous systems, 
somatomotor activity and behavior. 
 
9.1. Clinical signs of toxicity  
              All the rats were observed at least twice daily with the purpose of recording 
any symptoms of ill- health or behavioral changes. Clinical signs of toxicity daily for 
28 days. 
9.2. Food intake  
Prior to the beginning of treatment, and daily, the food intake of each cage was 
recorded for period of 28 days and the mean weekly intake per rats was calculated. 
 
9.3. Water intake 
Water intake was checked by visual observation during the Study. In addition, 
the water consumption in each cage was measured daily for a period of 28 days. 
 
 
PRE CLINICAL STUDY OF PADIGALINGA CHENDURAM Page 77 
 
9.4 Bodyweight: 
The body weight of each rat was recorded one week before the start of 
treatment, and during the course of the treatment on the day of initial, 3rd, 7th, 10th, 
14th, 17th, 20th, 24th and 28th days (day of sacrifice). The mean weights for the 
different groups and sexes were calculated from the individual weights. 
Blood Collection  
Blood was collected through retro-orbital sinus from all the animals of 
different groups on 28th day. The blood was collected in tubes containing 
Heparin/EDTA as an anticoagulant. Animals were fasted over night prior to the blood 
collection. 
 
LABORATORY STUDIES  
  During the 4th week of treatment, samples of blood were withdrawn from the 
orbital sinus of 6 males from each group, under light ether anesthesia after fasting for 
16 hours. The blood samples are used to evaluate Hematological   parameters like 
RBC, WBC, and PLATELETS etc….. The collected blood samples also centrifuged 
10000 rpm in 10 minutes to separate the serum. The separated serum used to evaluate 
biochemical parameters like SGOT, SGPT, ALP and BILIRUBIN ect……... 
Hematology  
The following hematological parameters were analysed using Autoanalyser  
Hb  : Haemoglobin (g %)  
PCV   : Packed Cell Volume 
WBC  : White Blood Corpuscles (x103/cmm)  
RBC  : Red Blood Corpuscles (x106/cmm)  
Blood Platelet count (x103/cmm)  
 
Differential WBC count:  
N  : Neutrophils (%)  
L  : Lymphocytes (%)  
M  : Monocytes (%)  
E  : Eosinophils (%)  
RDW  : Red Cell Distribution Width. 
MPV  : Mean Platelet Volume 
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Clinical Biochemistry:  
The following clinical Bio parameters were analysed using Auto analyser  
Total serum protein (g/dl)  
ALT/SGPT  : Alanine amino transferase (U/L)  
AST/SGOT  : Aspartate amino transferase (U/L)  
ALP    : Alkaline serum phosphatase (U/L)  
CHL    : Cholesterol (mg/dL)  
HDL    : High density lipoprotein 
TG    : Triglyceride 
 
MATERIALS AND METHODS 
ESTIMATION OF HEMATOLOGICAL PARAMETERS: 
1
 
Collection of blood for hematological studies 
After the treatment period the animals were anaesthetized by ketamine hydrochloride 
and the blood was collected from Retro-orbital sinus by using capillary into a 
centrifugation tube which contains EDTA for haematological parameters The 
haematological parameters like RBC, WBC and Hb percentage, Differential cell 
count, MCV, MCHC, Hematocrit, MCH, platelet count were estimated by the 
following procedures. 
 ENUMERATION OF RED BLOOD CELLS: 1    Ramnic 2007) 
Reagents : RBC diluting fluid 
     Procedure: 
         Using a red blood cell pipette of haemocytometer, well mixed blood was drawn 
up to 0.5 mark and RBC diluting fluid was taken up to mark II. The fluid blood 
mixture was shaken and transferred onto the counting chamber. The cells were 
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allowed to settle to the bottom of the chamber for 2 min. See the fluid does not get 
dried. Using 45X or high power objective the RBC‘s were counted uniformly in the 
larger corner squares.   
The cells were expressed as number of cells x10
12
/l 
 ENUMERATION OF WBC: 2    John 1972) 
  Reagents: 
 Turk‘s fluid: Turk‘s fluid was prepared by mixing 2ml of acetic acid with 100 
ml of distilled water. To this 10 drop of aqueous methylene blue 3 %    w/v) was 
added. This solution haemolysis the red cells due to acidity so that counting of 
white cells becomes easy. 
 
Procedure: 
Using a white blood cell pipette of haemocytometer, well mixed blood was 
drawn up to 0.5 mark and WBC diluting fluid was taken up to mark II. The fluid 
blood mixture was shaken and transferred onto the counting chamber. The cells were 
allowed to settle to the bottom of the chamber for 2 min. See the fluid does not get 
dried. 
 Using 10X or low power objective the WBC‘s were counted uniformly in the 
larger corner squares.  
 The cells were expressed as number of cells/10mm. 
 DIFFERENTIAL LEUCOCYTE COUNT: 3      John 1972) 
Reagent: 
              Leishmann‘s stain: 150mg of powdered leishmann‘s stain was dissolved in 
133ml of acetone free methanol. 
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Procedure: 
 A blood film stained with leishmann‘s stain was examined under oil 
immersion and the different types of WBCs were identified. The percentage 
distribution of these cells was then determined. Smears were made from anticoagulant 
blood specimens and stained with leishmann‘s stain. The slides were preserved for 
counting the number of lymphocytes and neutrophils, per 100 cells were noted.  
 From the different Leukocyte count and WBC count, absolute lymphocyte and 
neutrophil count were calculated. 
                                 Number of neutrophils  
 Absolute neutrophil count =   
_______________________________  
 x   TWBC 
                             100  
                                                                  Number of lymphocytes  
 Absolute lymphocyte count =   
_______________________________ 
 x  TWBC 
                             100 
J. C. Dacie and S. M. Lewis, Practical haematology, London: Churchill Livingstone, 1984, 
pp. 5. 
Measurement of biochemical parameters estimation 
Haemoglobin (Hb), was estimated using whole blood. Remaining parameters were 
measured in serum. All of the above biochemical parameters were estimated using 
semi-autoanalyzer (Photometer 5010 V5+, Germany) with enzymatic kits procured 
from Piramal Healthcare limited, Lab Diagnostic Division, Mumbai, India. 
 
Determination of aspartate aminotransferase (AST) 
Aspartate aminotransferase, also known as Glutamate Oxaloacetate Transaminase 
(GOT) catalyses the transamination of L-aspartate and α keto glutarate to form 
oxaloacetate and L- glutamate. Oxaloacetate formed is coupled with 2,4- 
Dinitrophenyl hydrazine to form hydrazone, a brown coloured complex in alkaline 
medium which can be measured colorimetrically. 
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Reagents  
Buffered aspartate  (pH 7.4); 2,4- DNPH reagent;  4N sodium hydroxide;  
working pyruvate standard; solution I (prepared by diluting 1 ml of reagent 3 to 10 ml 
with purified water). 
Procedure  
Rietman and Frankle method was adopted for the estimation of SGOT. (Reitmann S, 
Frankel S, 1957. A colorimetric method for the determination of serum oxaloacetic 
and glutamic pyruvate transminases. American Journal of Clinical Pathology.28: 56-
63.The reaction systems used for this study included blank, standard, test (for each 
serum sample) and control (for each serum sample). 0.25 ml of buffered aspartate was 
added into all the test tubes. Then 0.05 ml of serum was added to the test group tubes 
and 0.05 ml of working pyruvate standard into the standard tubes. After proper 
mixing, all the tubes were kept for incubation at 37
o
C for 60 min, after which 0.25 ml 
each of 2,4- DNPH reagent was added into all the tubes. Then, 0.05 ml of distilled 
water and 0.05 ml of each serum sample was added to the blank and the serum control 
tubes respectively. The mixture was allowed to stand at room temperature for 20 min. 
After incubation, 2.5 ml of solution I was added to all test tubes. Mixed properly and 
optical density was measured in a spectrophotometer at 505 nm within 15 min. 
 
The enzyme activity was calculated as:-  
AST (GOT) activity in IU/L) = [(Absorbance of test - Absorbance of control)/ 
(Absorbance of standard - Absorbance of blank)] x concentration of the standard     
 
Determination of alanine aminotransferase (ALT) 
Alanine aminotransferase, also known as Glutathione Peroxidase (GPT) catalyses the 
transamination of L-alanine and α keto glutarate to form pyruvate and L- Glutamate. 
Pyruvate so formed is coupled with 2,4 – Dinitrophenyl hydrazine to form a 
corresponding hydrazone, a brown coloured complex in alkaline medium which can 
be measured colorimetrically. 
 
PRE CLINICAL STUDY OF PADIGALINGA CHENDURAM Page 82 
 
Reagents 
Buffered alanine (pH 7.4), 2,4–DNPH, 4N sodium hydroxide, working pyruvate 
standard, solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with purified 
water). 
Procedure  
Rietman and Frankle method was dopted for the estimation of SGPT. The 
reaction systems used for this study included blank, standard, test (for each serum 
sample) and control (for each serum sample). 0.25 ml of buffered alanine was added 
into all the test tubes. This was followed by the addition of 0.05 ml of serum into the 
test group tubes and 0.05 ml of working pyruvate standard into the standard tubes. 
After proper mixing, all the tubes were kept for incubation at 37
o
C for 60 minutes, 
after which 0.25 ml each of 2,4- DNPH reagent was added into all the tubes. Then, 
0.05 ml of distilled water and 0.05 ml of each serum sample was added to the blank 
and the serum control tubes respectively. The mixture was allowed to stand at room 
temperature for 20 min. After incubation, 2.5 ml of solution I was added to all test 
tubes. Mixed properly and optical density was read against purified water in a 
spectrophotometer at 505 nm within 15 min. 
The enzyme activity was calculated as:- ALT (GPT) activity in IU/L) = 
[(Absorbance of test - Absorbance of control)/ (Absorbance of standard - Absorbance 
of blank)] x concentration of the standard.   
Determination of alkaline phosphatase (ALP) 
Alkaline phoshatase from serum converts phenyl phosphate to inorganic 
phosphate and phenol at pH 10.0. Phenol so formed reacts in alkaline medium with 4-
aminoantipyrine in presence of the oxidising agent potassium ferricyanide and forms 
an orange-red coloured complex, which can be measured spectrometrically. The color 
intensity is proportional to the enzyme activity. 
Reagents: 
Buffered substrate 
Chromogen Reagent 
Phenol Standard, 10 mg% 
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Procedure: 
ALP was determined using the method of Kind (Kind PRM, King EJ, 1972. 
In-vitro determination of serum alkaline phosphatase. Journal of Clinical Pathology 7: 
321-22\). The working solution was prepared by reconstituting one vial of buffered 
substrate with 2.2 ml of water. 0.5 ml of working buffered substrate and 1.5 ml of 
purified water was dispensed to blank, standard, control and test. Mixed well and 
incubated at 37
0
C for 3 min. 0.05 ml each of serum and phenol standard were added 
to test and standard test tubes respectively. Mixed well and incubated for 15 min at 
37
0
C. Thereafter, 1 ml of chromogen reagent was added to all the test tubes. Then, 
added 0.05 ml of serum to control. Mixed well after addition of each reagent and the 
O.D of blank, standard, control and test were read against purified water at 510 nm. 
Serum alkaline phosphatase activity in KA units was calculated as follows  
[(O.D. Test-O.D. Control) / (O.D. Standard- O.D. Blank)] x 10 
Determination of bilirubin  
In toxic liver, bilirubin levels are elevated. Hyperbilirubinemia can result from 
impaired hepatic uptake of unconjugated bilirubin, such a situation can occur in 
generalized liver cell injury, certain drugs (e.g Rifampin and probenecid) interfere 
with the rat uptake of bilirubin by the liver cell and may produce a mild unconjugated 
hyperbilirubinemia. Bilirubin level rises in diseases of hepatocytes, obstruction to 
bilirubin excretion into duodenum, in haemolysis and defects of hepatic uptake and 
conjugation of Bilirubin pigment such as Gilbert‘s disease.  
Elevation of total serum bilirubin may occur due to:  
1.Excessive haemolysis or destruction of the red blood cells.Eg:Haemolytic disease of 
the new born. 
2.Liver diseases.Eg.Hepatitis and cirrhosis. 
3.Obstruction of the biliary tract.Eg.Gall stones. 
The method is based on the reaction of Sulfonilic acid with sodium nitrite to 
form azobilirubin which has maximum absorbance at 546nm in the aqueous solution. 
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The intensity of the color Produced is directly proportional to the amount of direct or 
total bilurubin concentration present in the sample. 
Reagents 
1. Diazo A-(Reagent-R1) :Ready to use 
2. Diazo B-(Reagent-R2):Ready to use 
3. Bilirubin Activater :Ready to use 
 
Procedure 
Kind & King‘s method was followed for the estimation of Bilirubin. Five 
hundred µl of working reagent was added to 50 µl of rat serum & incubated for 5 min 
at 37°C. Absorbance was measured AT 546 NM in semi auto analyzer against the 
standard. 
The Bilirubin content was calculated using the following equation: 
Total bilirubin (mg/dt) = Abs of the sample blank x 15. 
 
Estimation of Urea
 
Urea is the nitrogen-containing end product of protein catabolism. States 
associated with elevated levels of urea in blood are referred to as hyper uremia or 
azotemia.  
 
Method 
Estimation of urea was done by Urease-GLDH: enzymatic UV test.  
 
Principle 
Urea + 2H2O     
Urease
       2NH4 + 2HCO3 
2- Oxoglutarate +NH4
+
 +NADH      
GLDH
      L- Glutamate +NAD
+
 + H2O                                         
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Table 14. Reagents 
 
 
 
 
 
 
 
 
 
 
Procedure 
a. Take 1000 μl of reagent-1 and 250 μl of reagent-2 in 5 ml test tube. 
b. To this, add 10 μl of serum. 
c. Mix well and immediately read the test sample at 340 nm Hg 334 nm Hg 365 
nm optical path 1 cm against reagent blank (2-point kinetic). 
d. And note down the value. 
Normal range: 10 – 50 mg/dl. 
 
ESTIMATION OF URIC ACID 
Uric acid and its salts are end products of the purine  metabolism. In gout the 
most common complication of  hyperuricemia, ie. Increased serum levels of uric acid 
lead to formation of  monosodium urate crystal around the joints. 
 
 
Method  
Enzymatic photometric test using  TOOS (N ethyl- N (hydroxyl -3- 
sulfopropyl)-m- toluidin) 
Principle  
Uric acid + H2O + O2       uricase         Allantoin +CO2 +H2O2 
 
TOOS + 4 aminoantipyrine + 2H2O2      
POD       
Indamine + 3H2O 
 
R 1 
TRIS pH 7.8 120  mmol/l 
2-Oxoglutarate 7 mmol/l 
ADP 0.6 mmol/l 
Urease ≥ 6 KU/l 
GLDH ≥ 1 KU/l 
R 2 NADH 0.25 mmol 
R 3 Standard 40 mg/dl 
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Table 15.reagents 
 
R1 Phosphate buffer pH 7.0 100mmol/l 
TOOS 1mmol/l 
Ascorbate oxidase ≥1 KU/l 
R2 Phosphate buffer pH 7.0 100mmol/l 
4- amino antipyrine 0.3mmol/l 
K4 (Fe( CN)6) 10µmol/l 
Peroxidase ≥1KU/l 
Uricase ≥50U/l 
 
Procedure 
a. Take 800µl of  reagents -1 in a2ml centrifuge tube. 
b. To this add 20µl of serum. 
c. Mix well and incubate at 30°c for 5 minutes. 
d. Then add 200µl of reagent2 
e. Mix well incubate for 5min at 37°c 
f. Measure the not down the values. 
Normal range: 1.9-8.2mg/dl 
 
ESTIMATION OF CREATININE:  
Estimation of Creatinine by Jaffe Method (modified) 
 
Principle: 
Creatinine forms a coloured complex with picrate in alkaline medium.  
The rate of formation of the complex is measured.  
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Reagents: 
Reagent 1    Standard Creatinine (2mg/100ml) 
Reagent 2    Picric acid solution 
Reagent 3      sodium hydroxide solution  
Procedure: 
 Take 500 μl of reagent -2 and 500 μl of reagent -3 in a 5ml test tube. To this 
add 100 μl of serum. Mix well and immediately read the test sample at Hg 492 nm 
1cm light path and note down the values.  
Normal range is 0.6 -1.1 mg/dl. 
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4.4.PHARMACOLOGICAL STUDY  
4.4.1.ANTI-DAIRRHOEAL ACTIVITY 
EFFECT OF PADIGALINGACHENDURAM ON CASTOR OIL - INDUCED 
SMALL INTESTINAL TRANSIT IN RATS 
               Diarrhea is one of the most common illnesses in all age groups. It is an 
uncomfortable condition that can have many causes, and vital gastroenteritis (stomach 
flu) is one of the most common causes of diarrhea. Diarrhea will normally heal itself 
within a few days. However, in some cases, diarrhea can lead to dehydration or be a sign 
of a more serious problem (Fontaine, 1988; Snyder and Merson, 1982). 
          Fontaine, O. (1988). Bacterial diarrhoea and treatment. Lancet. 1(8596): 1234 – 1235. 
 
MATERIAL AND METHODS 
 
ANIMALS: 
 
          Male Wister rats (140-180 and 180-200 g), were used in this study. All the animals 
were obtained from Animal house of the KMCH College of Pharmacy, Coimbatore. The 
animals were housed comfortably in a group of six in a single clean plastic cage with a 
metal frame lid on its top. They were housed under standard environmental conditions of 
temperature (24±1°C) and relative humidity of 30-70 %. A 12:12 h light dark cycle was 
followed. All animals had free access to water and standard pelletized laboratory animal 
diet ad libitum. All the experimental procedures and protocols used in this study were 
reviewed and approved via the Approval No. KMCRET/MD(S)/16/2016-2017 by the 
Institutional Animal Ethical Committee (IAEC) of KMCH College of Pharmacy, 
Coimbatore (685/PO/Re/S/2002/CPSCEA Dated 21
st
 August 2002 constituted in 
accordance with the guidelines of the CPCSEA, Government of India. 
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CASTOR OIL-INDUCED DIARRHEA IN RATS 
 
Male Wister rats were fasted 48 h, and water was given ad libitum. The water 
was withdrawn 1 h before starting the experiment. The experiment was performed 
according to the method of Venkatesan et al. (2005). Male Wister rats were given 0.5% 
carboxymethy cellulose (CMC) (orally) or atropine sulfate (intraperitoneally, i.p.). One 
hour later, they were given one milliliter castor oil orally and then weighed and placed 
individually in a transparent plastic box with absorbent paper underneath. Total amount 
of feces (in grams) after the castor oil administration was collected and weighed. 
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4.4.2.ANTI-PYRETIC ACTIVITY 
EFFECT OF PADIGALINGACHENDURAM ON BREWER’S YEAST 
INDUCED PYREXIA IN RATS 
                Pyrexia or fever is caused as a secondary impact of infection, malignancy or 
other diseased states. It is the body‘s natural function to create an environment where 
infectious agents or damaged tissues cannot survive. Normally, the infected or 
damaged tissue initiates the enhanced formation of pro inflammatory mediators 
(cytokines, such as interleukin 1β, α, β, And TNF- α), which increase the synthesis of 
prostaglandin (PgE2) near hypothalamic area and there by trigger the hypothalamus to 
elevate the body temperature. 
 
PROCEDURE 
Before yeast injection the basal rectal temperature of rats was recorded, 
Baseline body temperature was measured by inserting the digital rectal tele 
thermometer in to the anal cavity of the rat for  about 2 mins. The steady temperature 
readings obtained were recorded as the pre temperature. After recording animals were 
given subcutaneous injection of 10 ml/ kg of 15 % w/v yeast suspended in 0.5 % w/v 
carboxymethyl cellulose solution for elevation of body temperature of rats. Rats were 
then returned to their home cages. 18hrs after yeast injection, rats with elevated body 
temperature was selected for grouping and the PLC and standard drug was suspended 
in CMC and administered by gastric tube. 
Dosage schedule: 
The required dose for mice/rat will be calculated by using the standard dose 
calculation procedure from recommended clinical dose. 
Conversion formula: 
 human dose is 260mg,BD 
Total clinical dose (a)  x conversion factor (b) 0.018 = (c) per 200 gm of rat 
260 mg x 2(a) x 0.018 (b) = 4.68 mg (c) /kg  
4.6x1000/200 =  23mg/kg 
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Experimental Doses Calculated as per the standard procedures are: 
S.No Groups Dose /kg, 
weight 
Dose /200 
gms. weight 
Volume of 
administration 
 
1 Vehicle Control -- -- 0.5 ml 
2 Therapeutic 
Dose 
23mg 4.6mg 0.5 ml 
3 Average Dose 115mg 23mg 0.5 ml 
4 High Dose 230mg 46mg 0.5 ml 
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4.4.3.IN-VITRO ANTI-SPASMODIC ACTIVITY OF 
PADIGA LINGA CHENDURAM ON EXCISED RAT 
ILEUM 
ISOLATION OF RAT ILEUM:-  
 Rats were anesthetized and sacrificed by cervical displacement followed by 
exsanguinations. The ileum was dissected out, immersed in Tyrode‘ssolutionand 
cleaned off the mesentery. Respective segments of 2-3cm long were mounted in a 
25ml tissue organ bath, filled with a mixture of 95% O2 and 5% CO2 and maintained 
at 37 o C. The composition of Tyrode‘s solution (in mM for l lit) was 9 mg KCl, 0.1 
mg NaCl, 0.1mg NaHCO3, 0.42mg NaH2PO4, 0.6 mg Glucose and pH value was 7.4.  
ANTI-SPASMODIC ACTIVITY ASSAY PROCEDURE:-  
1. Firstly concentration dependent responses of acetylcholine were recorded (with 
dose of 0.1ml, 0.2ml, 0.4ml, 0.8ml, 1.6ml, 3.2ml) using Sherrington‘s recording 
drum with a frontal writing lever. Contact time of 60 sec, and base line of 30sec 
time cycle were opted for proper recording of the responses in presence of plane 
Tyrode‘s solution as stock-I solution.  
2.  Then same concentration dependent responses of acetylcholine (Ach) using same 
procedure for a mixture of Tyrode‘s solution+ Lantana camara extract (with a 
concentration of 1mg/ml) as a stock-II solution were recorded.  
3.  Lastly the same concentration dependent responses of Ach for a mixture of 
Tyrode‘s solution+ Atropine (as a standard antispasmodic agent) as a stock-III 
solution were recorded. 
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4.5.MICROBIOLOGICAL ANALYSIS 
ANTI-MICROBIAL ACTIVITIES BY WELL DIFFUSION METHOD 
 
Aim: 
The anti-microbial activity of padiga linga chenduram was adapted through 
well diffusion method (Agar diffusion testing) 
 
Principle  
The antimicrobials present in the plant extract are allowed to diffuse out into 
the medium and interact in a plate freshly seeded with the test organisms. The 
resulting zones of inhibition will be uniformly circular as there will be a confluent 
lawn of growth. The diameter of zone of inhibition can be measured in millimeters. 
 
Components of Muller Hinton agar medium: 
 Beef extract – 2gm/lit 
 Acid Hydrolysate of Casein – 17.5gm/lit 
 Starch – 1.5 gm/lit 
 Agar – 17 gm/lit 
 Distilled water – 1000 ml 
 PH -7.3±0.1 at 25
0 
C 
Procedure (Murray et al., 1995) 
 Petriplates containing 20ml Muller Hinton medium were seeded with 24hr 
culture of bacterial strains. Wells were cut and 20 µl of the plant extracts (aqueous) 
were added. The plates were then incubated at 37°C for 24 hours. The antibacterial 
activity was assayed by measuring the diameter of the inhibition zone formed around 
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the well (NCCLS, 1993). Streptomycin was used as a positive control. Standard  for 
an In-vitro antimicrobial activity of padiga linga chenduram was screened against 
bacteria strains such as Klebsiella pneumonia, Streptococcus mutans,staphylococcus 
aureus, Escherichia coli, Pseudomonas aerugina, Enterococcus faecalis. 
Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken HR Manual of Clinical 
Microbiology, 6th Ed. ASM Press, Washington DC, 1995; 15-18. 
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5. RESULTS AND DISCUSSION 
The Siddha drug Padiga linga chenduram had been subjected to various 
studies to establish the works of Siddhars to be true. Literary collections, 
physicochemical and Elemental analysis, toxicological study, pharmacological study 
and clinical study are done to prove the activity of   Padiga linga chenduram in Anti 
diarrhoeal activity. 
 Lingam and padikaram, is the chief ingredient of the medicine Padiga linga 
chenduram, is indicated for Kazhichal in Siddha literature. The experimental analysis 
was done to standardize the   padiga linga chenduram by its chemical compounds and 
particle size. 
Siddha standardization methods 
Siddhars used these following standardization methods to ensure the safety 
and efficacy of the chenduram. It shows the effectiveness of the drug. 
 Table No:1 Results of Siddha standardization 
     
S.NO Parameter Results of ideal  
chenduram 
Results of 
PC 
Interpretation  
1.  Colour Pink colour or red 
colour, no shining 
pink colour, 
no shining 
   One of the Ideal colours 
of chenduram. 
2.  Floating 
on Water 
Floats on water  Floats on 
water  
Lightness of drug. 
 
3.  Finger 
Print Test 
Impinged in the 
furrow of fingers 
Impinged in 
the furrow 
of fingers 
Indicates fine particles of 
powder. 
4.  Lustre Lustreless Lustreless Change of specific 
metallic character of raw 
material after incineration 
5.  Taste  No specific taste. No specific 
taste. 
Change of specific 
metallic character of raw 
material after incineration 
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             Finger Print Test     Colour (pink)
  
 
        
                                            Floating on Water            
PHYSIOCHEMICAL ANALYSIS OF PADIGA LINGA CHENDURAM 
Organoleptic Characters: 
 Colour                :    Pink colour 
                  Appearance         :    Powder 
                   Touch                 :    Nice 
                   Smell                  :    Odourless 
                   Taste                   :    Tasteless 
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   Physico- chemical standards:                    
                   Loss of Drying at 105
0
C :    7.8%    
                   Ash Content                    :   19.4%      
                   Ash insoluble Ash          :   7.5% 
         Ph     : 7.0 
                   Nice                                :   Fine powder 
                   Water Floated Test           :   Partly Floated. 
                     
    Microbial Limit test: 
                   Total Viable aerobic count     :   1.2 x 10
4
 col/g 
                   Total Enterobacteriaceae      :   Nil 
                       Total fungal count                :   Nil 
     Test for specific pathogens: 
                   Salmonella sp                     :   Nil    
                   Staphylococcus aureus           :  Nil 
                   E.coli                                     :  Nil 
                   Pseudomonas aeruginosa       :  Nil 
Interpretation:  
       Loss of drying value is 7.8% which confirms that padiga linga chenduram has nil 
moisture content and hence is very stable. 
       Total ash content is 19.4% ensure that padiga linga chenduram does not contain 
much inorganic impurities. 
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       As partical size is fine & as it floats of on water which is the desired properties of 
a chenduram, it is confirmed that it is well prepared. 
      Absence of Microbes ensures that it is free from contamination. 
THIN LAYER CROMATOGRAPHY (TLC):     
  
                            
 
Interpretation: 
            Spots of green, orange colours were detected on the chromatoplates under 
UVlight. The Rf value of spots in the sample was approximately 0.74, 0.73, 0.70, 
0.69, it indicates the presence of active compound in the sample which is responsible 
for the therapeutic effect. 
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BIO-CHEMICAL ANALYSIS OF “PADIGA LINGA CHENDURAM” 
Table No:2 Preliminary test for basic and acidic radical: 
S.no Experiment Inference 
1. Test for calcium: Absent 
2. Test for sulphate: Present 
3. Test for chloride: Present 
4. Test for carbonate: Absent 
5. Test for starch: Absent 
6. Test for iron ferric: Present 
7. Test for iron ferrous: Present 
8. Test for phosphate: Absent 
9. Test for albumin: Absent 
10. Test for tannic acid: Absent 
11.   test for unsaturation: Absent 
12. Test for the reducing sugar: Absent 
13.  test for amino acid:      Absent 
14. Test for zinc: Absent 
  
Interpretation: 
 Sulfur is a very versatile molecule, because it can exit in several distinct 
oxidative states, ranging from +6 in sulfate radicle to -2  in  hydrogen sulfide. 
Sulfur is a healing mineral and plays a role in metabolism. 
 
 Chloride: It even helps in maintaining proper kidney function and assists in 
keeping fluid flow through tissues and blood vessels efficient. 
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 Chloride, sodium, potassium regulate the acid-base balance of the body fluids. 
They regulate the water balance by maintaining the osmotic pressure of the 
body fluids. 
 
 Iron is a mineral. Most of the iron in the body is found in the hemoglobin of 
red blood cells and in the myoglobin of muscle cells. Iron is needed for 
transporting oxygen and carbon dioxide. It also has other important roles in 
the body. 
The heme containing enzymes such as catalase and peroxidase protect cell 
against potentially damaging highly reactive species. 
Iron is essential for many numbers of biological functions such as growth, 
reproduction, healing and immune function. 
Iron deficiency may be determined by measurement of iron levels within the 
body, mainly serum ferritin levels, which may also help distinguish between 
iron deficiency anemia and anemia associated with chronic disease, such as 
chronic kidney disease (CKD). 
SEM RESULT: 
                         
                                SEM picture  30,000 magnification 
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                                   SEM picture 5,000 magnification 
Interpretation: 
       The morphology of the Padiga linga chenduram sample can be determined by 
Environmental SEM (FEI Quanta). A representative portion of each sample must be 
sprinkled onto a double side carbon tape and mounted on aluminium stubs, in order to 
get a higher quality secondary electron image for SEM examination. We have 
observed from SEM photographs that particles are rounded in shapes and sizes are in 
the range from 5µm to 10 µm. Although the particle sizes of different batches showed 
similarity, it seems that these particles are aggregates of much smaller particles. When 
dispersed in an aqueous medium, these preparations form a negatively charged 
hydrophobic particle suspension. This hydrophobicity gives these particles a tendency 
to aggregate together to form larger particles. Padiga linga chenduram exhibited 
larger sizes and agglomeration of the particles. Therefore, the comparatively larger 
size may be due to the agglomeration of the particles by repeated cycles of 
calcinations involved in preparation. 
Siddhars were the great scientist in ancient times. They used nano technology 
for the preparation of chenduram, chenduram to treat chronic diseases. Nano particles 
have beneficial properties that can be used to improve drug delivery system. Target 
cells take up these nano particles quickly .Because of their smaller size,lesser particles  
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enhance the bio absorption and bio availability resulting efficacy of the drug will be 
increased. Larger particles could not enter in to the target cell because of their size, 
resulting in excretion from the body. If a drug is cleared too quickly from the body, 
this could force a patient to use high dose, poor bio distribution is a problem that can 
affect normal tissue through wide spread distribution but the particles from drug 
delivery systems lower the volume of distribution and reduce the effect on non target 
tissue. Adjuvant and detoxification (Purification) is also important factors for drug 
transport.  
 
FTIR RESULTS OF PADIGA LINGA CHENDURAM 
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Table No.3  Interpretation 
Absorption peak cm-1 Stretch Functional Group 
3500 - 3200 (s,b) O-H stretch, H – 
bonded 
Alcohols, phenols 
3300 – 2500 (m) O – H stretch Carboxylic acids 
1680 – 1640 (m) -C = C - Alkenes 
1500 – 1400 (m) C –C stretch (in – 
ring) 
Aromatics 
1320 – 1000 (s) C – 0 stretch Alcohols, carboxylic acids, 
esters, ethers 
1000 – 650 (s) =C – H bend Alkynes 
349  –  673 C-Br Stretch Alkyl Halides 
 
   
Interpretation: 
In FTIR the wave numbers between 4000cm
-1
-400cm
-1
 is known as functional 
group area.<400cm
-1
 wave number is known as finger print area. The corresponding 
absorption frequency by FTIR shows the presence of alcohols, phenols, alkenes, 
amines, aliphatic amines, alkyl halides.   
         It confirms that Padiga linga chenduram constitutes  Alcoholic,Phenolic,, 
Alkanes, Aromatics, Carboxylic acids , Esters, Ethers Alkyne, Alkyl halides, 1
0
,2
0
 
amines. 
 OH group has higher potential towards inhibitory activity against 
microorganisms.  
 Alcoholic group of act as antimicrobial activity. 
phenols 
 Phenols are also known as carbolic acid 
 Phenolic groups has anti microbial, anti oxidant activities. 
 Phenols as disinfectant prevent the development organisms. 
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Alkyl Halides: 
 These are group of compounds derived from alkanes containing one or more 
halogens. 
 Some are used as anesthetics and antiseptic agents. Some of them are used in 
medicine for the elimination of hook worms. 
Alkynes: 
 Alkyne is an unsaturated hydrocarbon containing one carbon –carbon triple 
bond,Some alkyne compounds which are physiologically acceptable salts are 
used as MCH antagonist . 
Esters: 
 Esters are organic compound formed when an acid combine with an alcohol 
and release water. 
Ether: 
 Ether is a class of organic compound characterized by an oxygen atom bonded 
to two alkyl or aryl group. 
Carboxylic acid 
 Carboxylic acid is class of organic compounds that are characterized by the 
presence of carboxyl group (-cooh) in them. 
 They make up a series of fatty acids which are extremely good for human 
health. The omega-6 and omega-3 are essential fatty acids which are not 
produced by the body. They help in maintaining the cell membrane and 
control nutrient use along with metabolism. 
ICP-OES (Inductively Coupled Plasma Optical Emission Spectroscopy): 
 
The drug (Padiga linga chenduram) sample was analysed by the Inductively 
Coupled Plasma Optical Emission Spectroscopy (ICP-OES) to detect the trace 
elements and other elements quantitatively. The result of ICP-OES is given on the  
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Table No: 4.  
Sample ID Elements Symbol Wavelength(nm) Concentration (A)P 
1 Al 396.152 BDL 
2 As 188.979 BDL 
3 Cd 228.802 BDL 
4 Cu 327.393 BDL 
5 Hg 253.652 3.012mg/L 
6 Ni 231.604 BDL 
7 Pb 220.353 BDL 
8 P 213.617 06.301mg/L 
9 S 180.731 71.304mg/L 
 
 
BDL:Below Detectable Limit ( Normal – 1 ppm) 
1% = 10000ppm, 
1ppm = 1/1000000 or 1ppm = 0.0001% 
 
The toxic metals and the permissible limits 
Heavy metals  WHO & FDA limits  
Arsenic (As)  10ppm 
Mercury (Hg)  1ppm 
Lead (Pb)  10ppm 
Cadmium (Cd) 0.3ppm 
 
Interpretation: 
The result indicate that the formulation is extremely safe as it contains heavy 
metals within specified limits.  
ICP-OES reveals high concentration of Hg(3.012mg/L), P(06.301mg/L), 
S(71.304mg/L),  in Padiga linga chenduram. It also has physiologically important 
minerals like . In Padiga ling a chenduram, the heavy metals like As, Hg, Cu, Cd, Pb 
and trace element like Ni, Al, were below detectable level.The mercury found in small 
concentration, This reveals the safety of the drug.  
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 The main ingredient of the Test drug is (lingam) mercurial compounds, but the 
final product shows below detection limit of the minerals. This results shows 
Below detection limit(BDL) of As(arsenic) ,Hg(Mercury), Cd (Cadmium), 
Pb(Lead),  Ni(Nikkal), Al(Aluminium), Cu (Copper).It is evident that the 
effectiveness of siddha medicine has been proved by the modern scientific 
way. 
 Sulfur is used to kill parasites (organisms that live on other organisms) such 
as fleas and ticks. 
 Sulfur is used to make proteins and nucleic acids, such as DNA. It also occurs 
in many essential enzymes. Enzymes are chemicals that make chemical 
reactions occur more quickly in cells. Humans usually have no problem 
getting enough sulfur in their diets. 
 Inorganic phosphorus is critical for numerous normal physiologic functions 
including skeletal development, mineral metabolism, energy transfer through 
mitochondrial metabolism, cell membrane phospholipid content and function, 
cell signaling, and even platelet aggregation.  
 Total adult body stores of phosphorus is approximately 700 g, of which 85% is 
contained in bone in the form of hydroxyapatite [(Ca)10(PO4)6(OH)2]. Of the 
remaining, 14% is intracellular, and only 1% is extracellular 
Effect of Acute Toxicity (14 Days) of PADIGALINGACHENDURAM 
RESULT    Table –1 Physical and behavioral examinations. 
Group no. Dose(mg/kg Observation sign No. of animal affected. 
Group-I 5mg/kg Normal 0 of 3 
Group- II 50mg/kg Normal 0 of 3 
Group-III 300mg/kg Normal 0 of 3 
Group-IV 1000mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
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Table-5 Home cage activity 
Functional 
and 
Behavioural 
observation 
Observation 5mg/kg 
Group 
(G-I) 
50mg/kg 
(G-II) 
300mg/kg 
(G-III) 
 
1000mg/kg 
(G-IV) 
2000mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body 
position 
Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Tonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 
Approach 
response 
Normal 3 3 3 3 3 
Touch 
response 
Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch 
response 
Normal 3 3 3 3 3 
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Table-6 Hand held observation 
Functional 
and 
Behavioral 
observatio
n 
Observati
on 
Contro
l 
5 mg/ 
kg  
(G-I) 
50 
mg/kg 
(G-II) 
300mg/
kg 
(G-III) 
1000mg/
kg 
(G-IV) 
2000mg/
kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 3 
Lacrimati
on 
Normal 3 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 3 
Piloerectio
n 
Normal 3 3 3 3 3 3 
Pupillary 
reflex 
Normal 3 3 3 3 3 3 
Abdomina
l tone 
Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
 
Table-7 Mortality 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
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INTERPRETATION 
From acute toxicity study it was observed that the administration of 
PADIGALINGACHENDURAM at a dose of 2000mg/kg, to a rats. From acute 
toxicity study it was observed that the administration of 
PADIGALINGACHENDURAM at a dose of 2000 mg/kg to the rats do not produce 
drug-related toxicity and mortality. So No-Observed-Adverse-Effect- Level (NOAEL) 
of PADIGALINGACHENDURAM is 2000 mg/kg. 
 
Discussion 
PADIGALINGACHENDURAM was administered single time at the dose of 
5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for 
consecutive 14 days after administration. Doses were selected based on the pilot study 
and literature review. All animals were observed daily once for any abnormal clinical 
signs. Weekly body weight and food consumption were recorded. No mortality was 
observed during the entire period of the study. Data obtained in this study indicated 
no significance physical and behavioural signs of any toxicity due to administration of 
PADIGALINGACHENDURAM at the doses of 5mg/kg, 50mg/kg , 300mg/kg, 
1000mg/kg and 2000mg/kg to rats.  
 
At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, hand held 
activity were observed. Home cage activities like Body position, Respiration, Clonic 
involuntary movement, Tonic involuntary movement, Palpebral closure, Approach 
response, Touch response, Pinna reflex, Sound responses, Tail pinch response were 
observed. Handheld activities like Reactivity, Handling, Palpebral closure, 
Lacrimation, Salivation, Piloercetion, Papillary reflex, abdominaltone, Limb tone 
were observed. Functional and behavioral examination was normal in all treated 
groups.Food consumption of all treated animals was found normal as compared to 
normalgroup. 
 
Body weight at weekly interval was measured to find out the effect of 
PADIGALINGACHENDURAM on the growth rate. Body weight change in drug 
treated animals was found normal. 
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Summary & conclusion: 
Summary: 
The present study was conducted to know single dose toxicity of 
PADIGALINGACHENDURAM on female wister rats. The study was conducted 
using 15 female Wister rats. The female animals were selected for study of 8- 12 
weeks old with weight range of within ± 20 % of mean body weight at the time of 
randomisation. The groups were numbered as group I, II, III, IV and V and dose with 
5mg/kg, 50mg/kg, 300mg/kg, 1000mg/kg and 2000mg/kg of 
PADIGALINGACHENDURAM. The drug was administered by oral route single 
time and observed for 14 days. Daily the animals were observed for clinical signs and 
mortality. Body weight of all animals was recorded once in a week. 
There were no physical and behavioral changes observed in albino mice of 
5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats during 14 days. 
Body weight of all animals did not reveal any significant change as compared 
to vehicle control group. 
Food consumption of all group animals was normal. 
Mortality was not observed in any treatment groups. 
 
Conclusion: 
The study shows that PADIGALINGACHENDURAM did not produce any 
toxic effect at dose of 5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to 
rats. So No-Observed-Adverse-Effect-Level (NOAEL) of 
PADIGALINGACHENDURAM is 2000 mg/kg. 
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 EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF PADIGA LINGA 
CHENDURAM ON BODY WEIGHT (PHYSICAL PARAMETER) 
 
EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF PADIGA LINGA 
CHENDURAM ON FOOD INTAKE IN gms 
 
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett‘s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF PADIGA LINGA 
CHENDURAM ON WATER INTAKE IN ML 
 
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett‘s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF 
PADIGALINGACHENDURAM ON ORGAN WEIGHT IN gms 
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Values arae expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett‘s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF 
PADIGALINGACHENDURAM ON BIOCHEMICAL PARAMETERS 
 
TOTAL BILRUBIN
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GROUP 
 
 
CONTROL 
 
LOW DOSE 
 
MIDEL DOSE 
 
HIGE DOSE 
 
TOTAL 
BILURBIN
E (g/ml) 
 
1.28867±0.1698
48 
 
 
1.66333±0.2123
15 
 
0.946667±0.1451
82 
 
0.696667±0.09243
62 
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF 
PADIGALINGACHENDURAM ON BIOCHEMICAL PARAMETERS 
 
 
 
 
 
 
 
 
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett‘s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
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GROUP 
 
 
CONTROL 
 
LOW DOSE 
 
MIDEL DOSE 
 
HIGE DOSE 
 
SGOT 
(U/L) 
 
100.133±5.78917 
 
114.6±13.4538 
 
97.3667±6.97838 
 
83.1±5.19711 
 
 
SGPT 
(U/L) 
 
50.37±9.515 
 
91.2±18.82 
 
47±5.677 
 
51.3±6.087 
 
 
ALP 
(U/L) 
 
184.3±41.41 
 
161.9±14.66 
 
156.2±37.88 
 
180.4±16.87 
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF PADIGA LINGA 
CHENDURAM ON BIOCHEMICAL PARAMETERS 
 
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett‘s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
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GROUP 
 
 
CONTROL 
 
LOW DOSE 
 
MIDEL DOSE 
 
HIGE DOSE 
 
UREA (mg/ml) 
 
23.43±5.143 
 
31.23±4.471 
 
26.7±2.309 
 
32±5.965 
 
 
URIC ACID 
(mg/ml) 
 
0.71±0.02517 
 
0.6567±0.1184 
 
0.73±0.06506 
 
0.6233±0.1146 
 
 
CREATININE  
(mg/ml) 
 
1.6±0.3612 
 
1.173±0.1369 
 
2.013±0.3238 
 
2.033±0.2958 
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INTERPRETATION: 
    CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the 
dosing   period of 28 days. 
 Mortality: 
All animals in control and in all the treated dose groups survived throughout 
the dosing period of 28 days. 
 Body weight: 
Results of body weight determination of animals Table-1 from control and 
different dose groups exhibited comparable body weight gain throughout the dosing 
period of 28 days. 
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Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food 
consumed by animals from different dose groups was found to be comparable with 
that by control animals. 
Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in 
Table No.4 Comparison of organ weights of treated animals with respective control 
animals on day 29 was found to be comparable similarly. 
Hematological investigations: 
The results of hematological investigations (Table 4) conducted on day 29 
revealed following significant changes in the values of different parameters 
investigated when compared with those of respective controls; however, the increase 
or decrease in the values obtained was within normal biological and laboratory limits 
or the effect was not dose dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on days 29 and recorded in 
Table 2 revealed the following significant changes in the values of hepatic serum 
enzymes studied. When compared with those of respective control. However, the 
increase or decrease in the values obtained was within normal biological and 
laboratory limits. 
 
Histopathology: 
In histopathological examination, revealed normal architecture in comparison 
with control and treated animal. 
DISCUSSION: 
1)  All the animals from control and all the treated dose groups up to 500 mg/kg 
survived throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during 
the dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain 
with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
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5)   Haematological analysis conducted at the end of the dosing period on day 29, 
revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29 no 
abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was found 
to be comparable with that of respective controls. 
8) Histopathological examination revealed normal architecture in comparison with 
control and treated animal. 
8.0 SUMMARY AND CONCLUSION:  
In conclusion PADIGALINGACHENDURAM can be considered safe, as it 
did not cause either any lethality or adverse changes with general behavior of rats and 
also there were no observable detrimental effects (100 to 300 mg/kg body weight) 
over a period of 28 days. Our results have demonstrated that the 
PADIGALINGACHENDURAM is relatively safe when administered orally in rats. 
 
ANTI-DIARRHOAL ACTIVITY  
EFFECT OF PADIGA LINGA CHENDURAM ON CASTOR OIL - INDUCED 
SMALL INTESTINAL TRANSIT IN RATS 
 
GROUP 
 
Total Length of 
Intestine 
 
Distance Travelled 
By Marker 
CHARCOAL 
 
 
%Intestinal Transit  
 
Control saline 
(2ml/kg i.p)  
 
 
90.4±1.3267 
 
0±0 
 
----- 
Castor oil (1ml 
p.o) +charcoal 
meal (1ml p.o) 
 
78.4±3.9192 
 
63.4±2.99333 
29.86 % 
Castor oil (1ml 
p.o) +Atropine 
(3mg/kg i.p) 
 
85.4±2.2271
 
 
36.4±2.27156 
53.57 % 
Castor oil (1ml 
p.o) + P C- 
4.6mg/kg 
 
80±5.1865 
 
50±2.91548 
 
41.45 % 
Castor oil (1ml 
p.o) + P C – 23 
mg/kg 
 
79±5.6921 
 
37±3.97492 
 
53.75 % 
Castor oil (1ml 
p.o) + P C – 
46mg/kg 
 
83.8±2.9052
 
 
26.4±2.92575 
 
66.58 % 
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Values arae expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett‘s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
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INTERPRETATION: 
 For  diarrhoea atrophine is astaudurd drug while compare with padiga 
linga chenduram its shous significant activity for diarrhoea in high dosage. 
ANTI-PYRETIC 
EFFECT OF PADIGALINGACHENDURAM ON BREWER’S YEAST 
INDUCED PYREXIA IN RATS 
GPS ONLY 
YEAST  
 
YEAST + 
PARACETA
MOL  (250 
mg) 
 
YEAST + P.C 
4.6mg/Kg 
 
 
YEAST + 
P.C 23mg/Kg  
 
YEAST + 
P.C 
46mg/Kg 
 
Initial Rectal 
Temperature 
0 hr 
59.5± 
18.818 
 
58.8333± 
18.6341 
 
59.5± 
18.9275 
 
60.8333± 
19.3088 
 
58.3333± 
18.462 
 
Rectal 
Temperature 
After  induction 
with Yeast 
         18hr 
 
78.8667± 
25.0261 
 
86.1833± 
27.4031 
 
79.6833± 
25.2823 
 
80.6667± 
25.6461 
 
85.5333± 
27.4643 
 
Rectal 
Temperature 
After  Treated  
with Test and 
Standard 
    1
st
hr 
 
84.9667± 
26.9434 
 
89.1± 
28.3479 
 
82.7833± 
26.2959 
 
83.6833± 
26.6027 
 
89.5167± 
28.7086 
 
 
   2
nd
hr 
 
81.9833± 
25.9936 
 
85.8167± 
27.1763 
 
78.3667± 
24.8392 
 
76.9833± 
24.4682 
 
84.9833± 
27.1018 
 
 
   3
rd
hr 
 
80.2333± 
25.3779 
 
78.8833± 
25.006 
 
76.2333± 
24.1443 
 
74.5± 
23.6678 
 
79.17± 
25.2165 
 
 
   4
th
hr 
 
81.8± 
25.8891 
 
77.35± 
24.4648 
 
73.3167± 
23.234 
 
72.7667± 
23.1295 
 
72.4667± 
23.1825 
 
 
   5
th
hr 
 
80.35± 
25.4619 
 
72.05± 
22.805 
 
68.6333± 
21.7313 
 
68.2167± 
21.6276 
 
67.8167± 
21.5417 
 
 
   6
th
hr 
 
80.1333± 
25.3455 
 
62.75± 
19.8828 
 
65.1± 
20.5934 
 
63.65± 
20.1531 
 
61.1± 
19.3378 
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EFFECT OF PADIGALINGACHENDURAM ON BREWER’S YEAST 
INDUCED PYREXIA IN RATS 
 
 
INTERPRETATION: 
 Thus padiga linga chenduram its shows significant activity for fever. 
 
ANTI-SPASMODIC ACTIVITY 
Dose Response Relationship Observations of Acetylcholine 
Si.No Concentration/dose Acetylcholine 
Response (cm) 
1 0.1 ml 3.2 cm 
2 0.2 ml 3.8 cm 
3 0.4 ml 4.9 cm 
4 0.8 ml 5.5 cm 
5 1.6 ml                      5.9 cm 
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Dose Response Relationship Observations of Atropine 
Si.No Concentration/dose atropine 
Response (cm) 
1 0.1 ml - 
2 0.2 ml - 
3 0.4 ml - 
4 0.8 ml - 
5 1.6 ml - 
 
Dose Response Relationship Observations of Acetylcholine and padiga linga 
chenduram 
Si.No Concentration/dose Acetylcholine + PC 
Response (cm) 
1 0.1 ml +0.1 ml 2.8 cm 
2 0.2 ml +0.2 ml 3.2 cm 
3 0.4 ml +0.4 ml 3.7 cm 
4 0.8 ml +0.8 ml 4.2cm 
5 1.6 ml + 1.6 ml 4.9 cm 
 
Comparative Dose Response of Ach and Ach followed by padigalingachenduram 
Si No Treatment  Dose(ml) response % of response 
1  
Acetylcholine 
0.1 ml 3.2 cm  
2 0.2 ml 3.8 cm  
3 0.4 ml 4.9 cm  
4 0.8 ml 5.5 cm  
5  1.6 ml 5.9 cm  
6  
Acetylcholine + 
padigalingachenduram 
0.1 ml +0.1 ml 2.8 cm 12.5 % 
7 0.2 ml +0.2 ml 3.2 cm 15.78 % 
8 0.4 ml +0.4 ml 3.7 cm 24.48 % 
9 0.8 ml +0.8 ml 4.2 cm 23.63 % 
10 1.6 ml + 1.6 ml 4.9 cm 16.94 % 
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Fig: Comparative dose response relationship of Acetylcholine and Padiga linga 
chenduram on excised rat ileum. 
INTERPRETATION: 
This revealed that padiga linga chenduram possess a high degree of 
spasmolytic (anti-spasmodic) activity by blocking cholinergic receptors. 
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MICROBIOLOGY RESULT 
 
Streptococcus mutant 
 
Enterococcus faecalis 
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Pseudomonas aeruginosa 
 
Staphylococcus aureus 
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E.coli 
 
Klebsiella pnemoniae 
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BACTERIA SAMPLE POSITIVE 
CONTROL 
(Streptomycin) 
NEGATIVE 
CONTROL 
E.coli 21mm 18mm NZ 
Klebsiella 
pnemoniae 
17mm 21mm NZ 
Staphylococcus 
aureus 
NZ 35mm NZ 
Streptococcus 
mutant 
NZ 21mm NZ 
Enterococcus 
faecalis 
21mm 30mm NZ 
Pseudomonas 
aeruginosa 
16mm 24mm NZ 
 
NZ – NO ZONE FORMATION 
* -  Diameter of inhibition zone less than 4 mm is represented as  ―–‖. 
14 mm-Low Sensitivity:15mm-Moderate:above 16mm-Highly sensitive 
 
INTERPRETATION: 
1.Escherchia.coli- Highly sensitive in 4 mg/disc 
2.Enterococcus faecalis- Highly sensitive in 4 mg/disc 
3. Streptococcus mutant - Low sensitive in 4 mg/disc 
4. Pseudomonas aeruginosa- Highly sensitive in 4mg/disc. 
5.Staphylococcusaureus-low sensitive in 4mg/disc  
6. Klebsiella pnemoniae - Highly sensitive in 4mg/disc 
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6.SUMMARY 
 The trial drug padiga linga chenduram was selected from the text ANUBOGA 
VAIDYA DEVA RAGASHIYAM, Page: 407, Edition-1 for the validation of safety, 
efficacy and its potency in Anti-diarrhoeal activity, Anti-pyretic and anti-
spasmodic activities. 
 
 The raw drugs padikaram, lingam were purchased from authorized drug store in 
Nagarcoil at kanyakumari district. The raw material was identified and 
authenticated by experts of PG Gunapadam department, Govt.Siddha Medical 
College, Palayamkottai, Tamilnadu. 
 
 The trial drug was prepared as per the standard operating procedure. Various 
literary collections of Siddha and Modern science about the ingredients of the 
drug supported the fact that padiga linga chenduram has anti-diarrhoeal activity.  
 
 The taste of patikaram in Astringent. This Astringent acts with pitha veerium 
according to pancha poothic theory astringent taste is a combination of primitive 
elements prithivi and vayu. The prithivi pootha have a character of produce 
dryness. These three characters very mach usefulmto treat the diarrhoea by 
making formed stools. 
 
 As per the original character of lingam can cure diarrhoea, as said in the quote 
“NgjpRuQre;ep ngUtpuzePnuhL”…… when both patikaram and lingam get 
combines means there is a good result for diarrhoea. By this ―PADIKALINGAM 
CHENDURAM‖ that treat ―DIARRHOEA‖ 
 
 The results  of Physico-chemical analysis confirm that the chenduram had fine 
particle with pink colour and low moisture content and did not contain free metals 
or microbes.Thus ensuring its safety and efficacy. 
 
 Chemical analysis revealed the presence of  sulfate, chloride, ferrous iron, ferric 
iron. 
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 Sulfur is just now becoming more widely appreciated as a really critical nutrient, 
without which many other things don‘t work properly, and most people are 
probably not getting enough sulfur from their diet anymore. For example, sulfur 
plays a critical role in detoxification, and also in inflammatory conditions. For 
detoxification, sulfur is part of one of the most important antioxidants that your 
body produces: glutathione. Without sulfur, glutathione cannot work. 
 
 sulfur plays an important role in the production of glutathione—one of the most 
important antioxidants that your body produces. Glutathione also serves important 
functions for detoxification. Without sulfur, glutathione cannot work. So, while 
not an antioxidant by itself, part of MSM‘s action is to improve your body‘s 
ability to make its own antioxidants. 
 A person who does not get enough sulfur in his or her diet develops certain health 
problems. These include itchy and flaking skin and improper development of hair 
and nails. Under very unusual conditions, a lack of sulfur can lead to death. Such 
conditions would be very rare, however. Eggs and meats are especially rich in 
sulfur. 
 
chloride 
 Some chloride-containing minerals include the chlorides of sodium (halite or 
NaCl), potassium (sylvite or KCl), and magnesium (bischofite), hydrated MgCl2. 
Called serum chloride, the concentration of chloride in the blood is regulated by 
the kidneys. A chloride ion is a structural component of some proteins, e.g., it is 
present in the amylase enzyme. So chloride is maintend by fluid and electrolyte 
balance help of the diarrhoeal  
 
 In industrial application, iron(III) chloride is used insewage 
treatment and drinking water production 
 SEM photographs  show that the particles are spherical in shapes and sizes are in 
the range from 0.5 micron to 1microns .The size of the particles enables better 
absorption.Hence the bioavailability is increased and even a minimal dose yields 
better results. 
 
PRE CLINICAL STUDY OF PADIGALINGA CHENDURAM Page 135 
 
FT-IR 
 Ester C is non acidic and gentle on the stomach   
 Phosphorous directly clears up indigestion, constipation, diarrhea, and generally 
tones up the digestive system for regular, healthy bowel movements. This 
increases the health of the digestive system, as well as that of the kidneys, since 
the toxins are being eliminated from the body, rather than recycling through the 
kidneys and stressing that system. 
 
 The acute study shows that PADIGALINGACHENDURAM did not produce any 
toxic effect at dose of 5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg 
to rats. So No-Observed-Adverse-Effect-Level (NOAEL) of 
PADIGALINGACHENDURAM is 2000 mg/kg. 
 
 
Acute Result: 
 From acute toxicity study it was observed that the administration of 
PADIGALINGACHENDURAM at a dose of 2000mg/kg, to a rats. do not 
produce drug-related toxicity and mortality. So No-Observed-Adverse-Effect- 
Level (NOAEL) of PADIGALINGACHENDURAM is 2000 mg/kg. 
 
SUB-ACUTE RESULTS: 
1)  All the animals from control and all the treated dose groups up to 500 mg/kg 
survived throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during 
the dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain 
with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
5)   Haematological analysis conducted at the end of the dosing period on day 29, 
revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29 no 
abnormalities attributable to the treatment. 
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7) Organ weight data of animals sacrificed at the end of the dosing period was found 
to be comparable with that of respective controls. 
8) Histopathological examination revealed normal architecture in comparison with 
control and treated animal. 
 Anti – diarrhoeal activity is carried out in rats by using charcoal meal method. The 
test drug padiga linga chenduram has significant Anti-diarrhoeal activity, which 
reveals the effectiveness of padiga linga chenduram in treating diarrhoea. 
 
 Anti-pyretic activity of test drug padiga linga chenduram carried out by using 
yeast-induced method. The drug padiga linga chenduram showed potent anti-
pyretic activity.     
 
 
 From all observations and results obtained for the present study it was concluded 
that padiga linga chenduram.,(Ghaneri) exhibits promising anti-spasmodic 
activity. Also when compared with a standard anti-spasmodic agent (atropine), it 
was found that padiga linga chenduram has comparatively less potent spasmolytic 
activity than atropine. 
 
 Anti-microbial study of the test drug padiga linga chenduram carried out by disc 
diffusion method. It observed that padiga linga chenduram is sensitive to 
Pseudomonas aeruginosa, Enterococcus faecalis, Klebsiella pnemoniae, E.coli. 
These padiga linga chenduram has significant anti-bacterial activity. 
 
 
 Thus the drug padiga linga chenduram found to be effective and safe for 
kazhitchal on basis of Anti-diarrhoeal, Anti-pyretic, Antispasmodic and Anti-
microbial action. 
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7. CONCLUSION 
Padiga linga chenduram was selected for the elaborate study of its efficacy on 
Kazhitchal (diarrhoea). 
From the literature review, Physico-chemical, Pharmacological, 
Microbiological, Biochemical, Instrumental analysis, It has been concluded that 
Padiga linga chenduram has got a good Anti-diarrhoeal, Anti-pyretic, and 
Antispasmodic hence effective for  diarrhoea. 
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8. FUTURE SCOPE OF STUDY 
 
              Having made up of nano particles, padiga linga chenduram holds 
extraordinary promise for the prevention and treatment of kazhitchal. This study 
directs future research in separating the compound responsible for this activity. It will 
open a new era of Receptor Targeted Treatment in the management of kazhitchal. 
Thus the ancient wisdom of Siddhars will remains as one important source of future 
medicine and therapeutics. 
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